<!DOCTYPE article
 PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2 20190208//EN" "JATS-archivearticle1.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="preprint"><?all-math-mml yes?><?use-mml?><?origin ukpmcpa?><front><journal-meta><journal-id journal-id-type="nlm-ta">bioRxiv</journal-id><journal-title-group><journal-title>bioRxiv : the preprint server for biology</journal-title></journal-title-group><issn pub-type="epub">2692-8205</issn></journal-meta><article-meta><article-id pub-id-type="manuscript">EMS202321</article-id><article-id pub-id-type="doi">10.1101/2024.12.20.629649</article-id><article-id pub-id-type="archive">PPR958060</article-id><article-version-alternatives><article-version article-version-type="status">preprint</article-version><article-version article-version-type="number">1</article-version></article-version-alternatives><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Genomic Characterisation of Group B <italic>Streptococcus</italic> from Argentina: Insights into Prophage Diversity, Virulence Factors and Antibiotic Resistance Genes</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Kovacec</surname><given-names>Veronica</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Di Gregorio</surname><given-names>Sabrina</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="aff" rid="A2">2</xref></contrib><contrib contrib-type="author"><name><surname>Pajon</surname><given-names>Mario</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Khan</surname><given-names>Uzma Basit</given-names></name><xref ref-type="aff" rid="A3">3</xref></contrib><contrib contrib-type="author"><name><surname>Poklepovich</surname><given-names>Tomas</given-names></name><xref ref-type="aff" rid="A4">4</xref></contrib><contrib contrib-type="author"><name><surname>Campos</surname><given-names>Josefina</given-names></name><xref ref-type="aff" rid="A4">4</xref><xref ref-type="fn" rid="FN1">5</xref></contrib><contrib contrib-type="author"><name><surname>Crestani</surname><given-names>Chiara</given-names></name><xref ref-type="aff" rid="A5">6</xref></contrib><contrib contrib-type="author"><name><surname>Bentley</surname><given-names>Stephen D.</given-names></name><xref ref-type="aff" rid="A3">3</xref></contrib><contrib contrib-type="author"><name><surname>Jamrozy</surname><given-names>Dorota</given-names></name><xref ref-type="aff" rid="A3">3</xref></contrib><contrib contrib-type="author"><name><surname>Mollerach</surname><given-names>Marta</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="aff" rid="A2">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3855-0553</contrib-id><name><surname>Bonofiglio</surname><given-names>Laura</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="aff" rid="A2">2</xref><xref ref-type="corresp" rid="CR1">*</xref></contrib></contrib-group><aff id="A1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/0081fs513</institution-id><institution>Universidad de Buenos Aires</institution></institution-wrap>. Facultad de Farmacia y Bioquímica. Instituto de Bacteriología y Virología Molecular. <city>Buenos Aires</city>, <country country="AR">Argentina</country></aff><aff id="A2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03cqe8w59</institution-id><institution>CONICET</institution></institution-wrap>, <city>Buenos Aires</city>, <country country="AR">Argentina</country></aff><aff id="A3"><label>3</label>Parasites and Microbes Programme, <institution-wrap><institution-id institution-id-type="ror">https://ror.org/05cy4wa09</institution-id><institution>Wellcome Sanger Institute</institution></institution-wrap>. <city>Cambridgeshire</city>, <country country="GB">United Kingdom</country></aff><aff id="A4"><label>4</label>Unidad Operativa Centro Nacional de Genómica y Bioinformática, ANLIS Dr. Carlos G. Malbrán, Buenos Aires, Argentina</aff><aff id="A5"><label>6</label>Global Health Department, <institution-wrap><institution-id institution-id-type="ror">https://ror.org/0495fxg12</institution-id><institution>Institut Pasteur</institution></institution-wrap>. <city>Paris</city>, <country country="FR">France</country></aff><author-notes><corresp id="CR1">
<label>*</label>Corresponding author: <email>lbonofi@ffyb.uba.ar</email> (LB)</corresp><fn id="FN1" fn-type="present-address"><label>5</label><p id="P1">Current Address: International Pathogen Genomic Surveillance Network (IPSN). WHO Berlin Hub</p></fn></author-notes><pub-date pub-type="nihms-submitted"><day>17</day><month>01</month><year>2025</year></pub-date><pub-date pub-type="preprint"><day>23</day><month>12</month><year>2024</year></pub-date><permissions><ali:free_to_read/><license><ali:license_ref>https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This work is licensed under a <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">CC BY 4.0 International license</ext-link>.</license-p></license></permissions><abstract><p id="P2">Group B <italic>Streptococcus</italic> (GBS) is a commensal bacterium that can cause severe infections in infants and adults with comorbidities. Resistance and reduced susceptibility to antibiotics is continually on the rise, and vaccines remain in-development. Prophages have been reported to contribute to GBS evolution and pathogenicity. However, no studies are available to date on prophage contribution to the epidemiology of GBS isolates from humans in South America. In the context of an Argentinian multicentric study, we had previously phenotypically characterised 365 human GBS isolates from invasive disease, urinary infections and maternal colonisation. These isolates had been whole genome sequenced and their prophage presence bioinformatically determined. In this study, we genomically characterised the isolates and analysed the prophage content in the context of the epidemiological data. The phylogenetic analysis of the 365 genomes with 103 GBS from public databases revealed that Argentinian GBS were related to isolates from around the world. The most prevalent lineages, independently of the isolate source, were CC23/Ia and CC12/Ib. Genes encoding virulence factors involved in immune response evasion, tissue damage and adherence to host tissues and invasion were found in all of the genomes in accordance with previously described lineage distribution. According to the prevalent capsular types and the distribution of specific virulence factors in Argentinian GBS, over 95% coverage would be expected from the vaccines currently under development. Antibiotic resistance determinants (ARDs) to at least one antibiotic class were found in 90% of the genomes, including novel mutations in <italic>pbp</italic>2x, while more than 15% carried ARDs to 3 or more classes. GBS collected from urinary infections carried a significantly higher proportion of ARDs to multiple antibiotic classes than the rest of the isolates. A total of 454 prophages were found among the 468 genomes analysed, which were classified into 23 prophage types. Prophage presence exhibited variations based on GBS clonal complex and capsular type. A possible association between an increased GBS pathogenicity and the carriage of prophages with integrase type GBS <italic>Int</italic>8 and/or the presence of genes that encode the Phox Homology domain has been observed. The highest prevalence of prophages per genome was found in lineages CC17/III and CC19/III, while the lowest amount was observed in CC12/Ib. Overall, the highest density of prophages, virulence factors and ARDs determinants was found in CC19 isolates, mostly of capsular type III, independently of the isolates source. This is the first analysis of the human-associated GBS population in South America based on whole genome sequencing data, which will make a significant contribution to future studies on the global GBS population structure.</p></abstract><kwd-group><kwd><italic>Streptococcus agalactiae</italic></kwd><kwd>group B Streptococcus</kwd><kwd>GBS</kwd><kwd>Argentina</kwd><kwd>Epidemiology</kwd><kwd>Prophage</kwd></kwd-group></article-meta></front><body><sec id="S1" sec-type="intro"><title>Introduction</title><p id="P3"><italic>Streptococcus agalactiae</italic> (group B <italic>Streptococcus</italic>; GBS) is a commensal bacterium that colonises the human intestinal and genitourinary tracts. GBS is the leading cause of neonatal sepsis and other perinatal infections such as meningitis and pneumonia (<xref ref-type="bibr" rid="R1">1</xref>). In recent decades, there has been a marked increase in the incidence of invasive infections caused by GBS in non-pregnant individuals, especially in the elderly and those suffering from underlying medical conditions (<xref ref-type="bibr" rid="R2">2</xref>–<xref ref-type="bibr" rid="R8">8</xref>). Advanced age, diabetes <italic>mellitus</italic> and cancer have been postulated as the main risk factors for GBS invasive disease in adult patients (<xref ref-type="bibr" rid="R7">7</xref>,<xref ref-type="bibr" rid="R9">9</xref>,<xref ref-type="bibr" rid="R10">10</xref>).</p><p id="P4">Penicillin is the first-line drug for the treatment and prevention of GBS infections and combination of both penicillin and gentamicin is indicated for sepsis in infants (<xref ref-type="bibr" rid="R11">11</xref>,<xref ref-type="bibr" rid="R12">12</xref>). In patients with penicillin allergy macrolides/lincosamides are used (<xref ref-type="bibr" rid="R13">13</xref>,<xref ref-type="bibr" rid="R14">14</xref>), while vancomycin is reserved for cases of macrolides/lincosamides resistance (<xref ref-type="bibr" rid="R15">15</xref>). Macrolide and lincosamide resistance has been gradually increasing in the last decades (<xref ref-type="bibr" rid="R16">16</xref>–<xref ref-type="bibr" rid="R20">20</xref>). Resistance to other antibiotic families has also emerged, such as reduced susceptibility to beta-lactams (<xref ref-type="bibr" rid="R21">21</xref>) as well as resistance to aminoglycosides (<xref ref-type="bibr" rid="R22">22</xref>), vancomycin (<xref ref-type="bibr" rid="R23">23</xref>) and fluoroquinolones (<xref ref-type="bibr" rid="R24">24</xref>). This has been associated with dissemination of multidrug resistant (MDR) clones (<xref ref-type="bibr" rid="R2">2</xref>–<xref ref-type="bibr" rid="R5">5</xref>,<xref ref-type="bibr" rid="R8">8</xref>,<xref ref-type="bibr" rid="R18">18</xref>).</p><p id="P5">To date, there are no approved vaccines for the prevention of GBS infections, but there are several serotype-specific or protein-based vaccines in development (<xref ref-type="bibr" rid="R25">25</xref>). The impact of the vaccine-based prevention will depend on vaccine coverage according to the selected antigens, so it is imperative to study the diversity of GBS isolates circulating in each region. An international consortium called Juno was established to analyse the diversity, vaccine target distribution and genetic determinants associated with GBS infection worldwide (<ext-link ext-link-type="uri" xlink:href="https://www.gbsgen.net/">https://www.gbsgen.net/</ext-link>).</p><p id="P6">Prophages are important vehicles for horizontal gene transfer (HGT) (<xref ref-type="bibr" rid="R26">26</xref>) and they play a significant role in bacterial evolution by introducing genes that enhance bacterial fitness and virulence (<xref ref-type="bibr" rid="R27">27</xref>,<xref ref-type="bibr" rid="R28">28</xref>). Up to 20% of bacterial genomes can be constituted by prophages and it has been described that pathogenic strains tend to carry more phage-related genes than non-pathogenic strains (<xref ref-type="bibr" rid="R29">29</xref>–<xref ref-type="bibr" rid="R31">31</xref>), which was also observed for GBS (<xref ref-type="bibr" rid="R32">32</xref>).</p><p id="P7">Recent studies on the role of lysogeny in the evolution and pathogenicity of human GBS isolates revealed that acquisition of certain prophages (of possible animal origin) might have been related to the emergence of specific GBS clones that were pathogenic for infants or adults in Europe (<xref ref-type="bibr" rid="R32">32</xref>–<xref ref-type="bibr" rid="R35">35</xref>). Whether such association between prophage content and GBS pathogenicity is present in other geographical areas is unknown.</p><p id="P8">We previously analysed the prophage content of 365 GBS genomes from Argentina, detecting 325 prophages, which were classified into 19 prophage types, and found significant associations between the prevalent prophage types and certain GBS clonal complexes (<xref ref-type="bibr" rid="R36">36</xref>). The present study aims to characterise further genomic diversity of the 365 Argentinian GBS isolates as well as the prophage presence in the context of the epidemiological data.</p></sec><sec id="S2" sec-type="methods"><title>Methods</title><sec id="S3"><title>Genomes used in this study</title><p id="P9">Within the framework of a Argentinian national multicentric study that involved 40 health centres in 12 provinces of Argentina and took place in 2014-2015, we collected 450 GBS isolates from invasive or urinary infections as well as colonised pregnant women. All isolates had been previously characterised phenotypically and genotypically by PFGE (<xref ref-type="bibr" rid="R3">3</xref>–<xref ref-type="bibr" rid="R5">5</xref>) and 365/450 were whole genome sequenced as part of the Juno project. The geographic coverage of the 365 Argentinian GBS genomes can be visualized in the microreact project created for this study (<ext-link ext-link-type="uri" xlink:href="https://microreact.org/project/gbs-pangenomic-analysis">https://microreact.org/project/gbs-pangenomic-analysis</ext-link>). Sequencing and raw sequence data handling methodology were described previously (<xref ref-type="bibr" rid="R36">36</xref>). The dataset was divided into four collections. The infant invasive collection (iiGBS, N=22) from infants between 1 and 90 days of age with an invasive infection (13/22 from early-onset disease - EOD; 9/22 from late-onset disease -LOD). The non-infant invasive collection (niGBS, N=133) from children over 3 months old (N=3) and adults (N=130). The urinary infection collection (uGBS, N=145) from adolescents (aged 16 to 17 years, N=4) and adults (N=141). The colonising collection (cGBS, N=85) from adolescent (aged 14 to 17 years, N=8) and adult (N=77) pregnant women.</p><p id="P10">The dataset was supplemented with 103 whole genome GBS assemblies from humans collected in 16 countries across 5 continents, retrieved from NCBI under the category of RefSeq (<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/">https://www.ncbi.nlm.nih.gov/</ext-link>, accessed in August 2022), (Supplementary Table S1). Assemblies were selected based on the following criteria: 1) isolates from children or adults suffering from invasive or urinary infections, or from colonisation; 2) isolates representing clonal complexes common among GBS from infections in humans in Argentina (CC23, CC17, CC19, CC1, CC12, CC452, data from this work); 3) isolates collected during time period that aligned with the sampling period of our isolates. For more information about these isolates see the <underline>microreact project</underline>.</p></sec><sec id="S4"><title>GBS genomic characterisation</title><p id="P11">The steps followed for GBS characterisation are detailed in this section and summarised in Supplementary Figure 1.</p><p id="P12">To reconstruct a core-SNP phylogeny, the 468 assemblies (365 from Argentina plus 103 from the global dataset) were annotated with Prokka v1.14.5 (<xref ref-type="bibr" rid="R37">37</xref>) and a core gene alignment was generated with Roary v3.13.0 (<xref ref-type="bibr" rid="R38">38</xref>). Single nucleotide polymorphisms (SNPs) were identified with SNP-sites v2.5.1 (<xref ref-type="bibr" rid="R39">39</xref>). A maximum-likelihood (ML) phylogenetic tree was reconstructed using IQ-TREE v1.6.12 (<xref ref-type="bibr" rid="R40">40</xref>), with automatic selection of the substitution model and 1000 SH-aLRT (<xref ref-type="bibr" rid="R41">41</xref>) and 1000 ultrafast-bootstrap (<xref ref-type="bibr" rid="R42">42</xref>) replicates for branch support analysis.</p><p id="P13">Capsular types were determined by sequence similarity between the assemblies and reference capsular gene sequences of the 10 GBS capsular types, through a blastn (BLAST v2.9.0+, <ext-link ext-link-type="uri" xlink:href="https://blast.ncbi.nlm.nih.gov/Blast.cgi">https://blast.ncbi.nlm.nih.gov/Blast.cgi</ext-link>) search (E value threshold of 1e<sup>-100,</sup> otherwise default parameters), as described by Sheppard (<xref ref-type="bibr" rid="R43">43</xref>). As these authors did not publish the reference sequence of the serotype IX capsular gene, the <italic>cps</italic>O gene sequence used by Breeding (<xref ref-type="bibr" rid="R44">44</xref>) for capsular type IX detection by PCR was incorporated into the capsular gene database. In all cases, a capsular type was assigned when there was at least 95% of sequence identity over 90% of the sequence length. The results were compared with those previously obtained by phenotypic serotyping conducted on the same isolate collection (<xref ref-type="bibr" rid="R3">3</xref>,<xref ref-type="bibr" rid="R5">5</xref>,<xref ref-type="bibr" rid="R4">4</xref>). A comparative analysis between the capsular type loci (<italic>cps</italic>) of non-typable isolates and reference strains (<xref ref-type="bibr" rid="R45">45</xref>) of each capsular type (Supplementary Table S2) was performed with clinker v0.027 (<xref ref-type="bibr" rid="R46">46</xref>).</p><p id="P14">MLST was determined with the software mlst v2.22.1 (<xref ref-type="bibr" rid="R47">47</xref>). The pubMLST website (<ext-link ext-link-type="uri" xlink:href="https://pubmlst.org/organisms/streptococcus-agalactiae">https://pubmlst.org/organisms/streptococcus-agalactiae</ext-link>) (<xref ref-type="bibr" rid="R48">48</xref>,<xref ref-type="bibr" rid="R49">49</xref>) was used for sequence type (ST) assignment when new alleles were detected and to assign each ST to a clonal complex (CC).</p><p id="P15">Prophage screening and typing was performed with a methodology previously developed for GBS-prophage detection and their classification in prophage types (<xref ref-type="bibr" rid="R36">36</xref>), according to their phylogenetic group and integrase type. Shortly, GBS genomes were searched for genes specific to each prophage type by the following methodology: i) blastn search against the Prophage-group database (<xref ref-type="bibr" rid="R36">36</xref>); a positive result was considered when at least one of the prophage group-specific genes was detected with at least 75% of sequence identity over 75% of the sequence length; in the special case of group A prophages, at least two genes should be detected: <italic>hha</italic>I <bold>or</bold> <italic>clp</italic>P <bold>and</bold> the gene coding for the holin <bold>or</bold> the lysin. ii) blastx search against the Prophage-integrase database (<xref ref-type="bibr" rid="R36">36</xref>,<xref ref-type="bibr" rid="R50">50</xref>); a positive result was considered when the integrase gene was detected with at least 90% of sequence identity over 95% of the sequence length. iii) Prophage classification by prophage type: integration of classifications by prophage group/integrase type.</p><p id="P16">Virulence determinants (VDs) were searched with Abricate v0.9.9 (<xref ref-type="bibr" rid="R51">51</xref>), using the VFDB database v2023-06-27 (<xref ref-type="bibr" rid="R52">52</xref>) and by a blastn v2.9.0+ search against a reference database of genes coding for surface proteins involved in GBS virulence (<xref ref-type="bibr" rid="R53">53</xref>). In all cases, the threshold for gene detection was established as 80% identity over 80% of the reference sequence length.</p><p id="P17">Antibiotic resistance determinants (ARDs) were searched with Abricate v0.9.9, using the ResFinder database v2023-06-27 (<xref ref-type="bibr" rid="R54">54</xref>) and AMRFinderPlus v3.11.4, database v2023-04-17.1 (<xref ref-type="bibr" rid="R55">55</xref>). Additionally, a blastn v2.9.0+ search was performed against two reference databases created by Metcalf (<xref ref-type="bibr" rid="R56">56</xref>) for specific detection of ARDs in GBS genomes, including known variants of the PBP2x transpeptidases (<xref ref-type="bibr" rid="R57">57</xref>) and resistance determinants to quinolones and several other antibiotic families (<xref ref-type="bibr" rid="R58">58</xref>). In all cases, the threshold for gene detection was established as 80% identity over 80% of the reference sequence length. In the case of allelic variants of genes coding for PBP2x or the genes involved in quinolone resistance (<italic>par</italic>C and <italic>gyr</italic>A), novel variants were considered those without 100% identity with any reference variant. The results were compared with those previously obtained by phenotypic analysis (<xref ref-type="bibr" rid="R3">3</xref>,<xref ref-type="bibr" rid="R5">5</xref>,<xref ref-type="bibr" rid="R59">59</xref>).</p></sec><sec id="S5"><title>Integration of information</title><p id="P18">The Microreact application (<xref ref-type="bibr" rid="R60">60</xref>) was used for an integral visualisation of the genomic analysis results. All the information collected was evaluated in the context of both the whole set of genomes and each of the Argentinian GBS collections.</p></sec><sec id="S6"><title>Statistical analysis</title><p id="P19">Chi-squared and Fisher’s exact test (two-tailed) were used to evaluate distribution and correlation of categorical variables. A <italic>p</italic>-value of ≤0.05 was considered to be significant.</p></sec></sec><sec id="S7" sec-type="results"><title>Results</title><sec id="S8"><title>Phylogenetic and lineage analysis of GBS genomes</title><p id="P20">The core-SNP phylogeny showed that Argentinian isolates clustered with the globally derived human GBS. Cluster distribution correlated with CC and, in most cases, with capsular type (<xref ref-type="fig" rid="F1">Figure 1</xref>).</p><p id="P21">Significant associations (<italic>p</italic>&lt;0.05) were found between the most prevalent capsular types and clonal complexes: CC23/Ia, CC452/Ia, CC12/Ib, CC19/II, CC23/II, CC17/III, CC19/III and CC1/V. Lineages CC23/Ia and CC12/Ib were the most prevalent among all Argentinian isolates (31% and 17%, respectively) and in each of the Argentinian collections (<xref ref-type="fig" rid="F2">Figure 2</xref>). A similar distribution of lineages was observed in each collection, with the exception of the lineage CC19/III, whose frequency was significantly higher in uGBS and lower in niGBS (<italic>p</italic>&lt;0.05in both cases). Eleven new sequence types (ST) belonging to prevalent CCs were found among Argentinian genomes and submitted to the pubMLST database.</p></sec><sec id="S9"><title>Analysis of capsular type discrepancies and non-typeable GBS isolates</title><p id="P22">The comparison between the <italic>in silico</italic> and phenotypic capsular typing of the Argentinian isolates revealed 85% correlation. In the discrepant 15%, there was no correlation between the capsular type and the differing serotype, that is, the same discrepancies were not always found between both methods (Supplementary Table S3). All results shown in this study regarding capsular type were obtained <italic>in silico</italic>, as described in the Methods section.</p><p id="P23">Five out of the 468 isolates were classified as non-typeable (NT) by <italic>in silico</italic> analysis (Supplementary Table S4). This included three Argentinian GBS, two of which were phenotypically non-typable and one typed as serotype Ia. All NT genomes were searched manually for the <italic>cps</italic> operon (constituted by <italic>cps</italic> and <italic>neu</italic> genes). In 3/5 isolates the failure of capsular typing could be explained by deletion of all <italic>cps</italic> genes, with presence of only <italic>neu</italic> genes. The two remaining NT isolates presented seemingly complete <italic>cps</italic> operons, and were compared against reference sequences of each capsular type (Supplementary Figure 2). Isolate JN_AR_GBS348 (CC19, from Argentina), shared the highest homology (&gt;94%) with capsular type III, but contained a truncated copy of the <italic>cps</italic>J gene (Supplementary Figure 3A). The strain MIN-180 (CC452, from the United Kingdom), shared 100% homology with all capsular type V operon genes, except for the <italic>cps</italic>O gene due to insertion of IS5-like transposases (Supplementary Figure 3B).</p></sec><sec id="S10"><title>Prophage presence in the context of GBS epidemiology</title><p id="P24">We reported previously the detection and classification of 325 prophages within this dataset of 365 Argentinian GBS (<xref ref-type="bibr" rid="R36">36</xref>). In this study, the prophage presence was analysed in the context of GBS epidemiological data.</p><p id="P25">A total of 454 prophages were found among the 468 genomes analysed here, and classified into 23 prophage types. The presence of 1 or 2 prophages per isolate was the most common, though some isolates carried up to four prophages. Prophage type distribution was analysed in the context of GBS phylogeny as well as CC and capsular type assignment (<xref ref-type="fig" rid="F3">Figure 3</xref>).</p><p id="P26">Within the predominant lineages, the highest number of prophages per genome was found in CC17/III and CC19/III, while the lowest in CC12/Ib (<xref ref-type="fig" rid="F3">Figure 3</xref>). A significant association was observed (<italic>p</italic>&lt;0.05) between the following lineages and prophage types (Supplementary Figure 4): CC23/Ia with E1/GBS<italic>Int</italic>3 and A; CC12/Ib with F1/GBS<italic>Int</italic>11.2; CC1/V with A; CC19/III with E2/GBS<italic>Int</italic>3, A and D/GBS<italic>Int</italic>1; CC17/III with C/GBS<italic>Int</italic>4, D/GBS<italic>Int</italic>1 and B/GBS<italic>Int</italic>9.2; CC452/Ia with E1/GBS <italic>Int</italic>3; CC23/II with E2/GBS<italic>Int</italic>3.</p><p id="P27">Interestingly, 13/15 prophages with integrase type GBS<italic>Int</italic>8.1 or GBS<italic>Int</italic>8.2 were detected in isolates from invasive or urinary infections, but were absent in isolates from vaginal carriage. The remaining 2/15 were found in global isolates from unknown origin. These prophages were found in GBS from six different lineages: 4/15 CC103/Ia, 1/15 CC12/Ib, 2/15 CC17/III, 1/15 CC22/II, 6/15 CC23/Ia and 1/15 CC23/II.</p><p id="P28">While Argentinian isolates from all collections carried predominantly E1/GBS<italic>Int</italic>3, E2/GBS<italic>Int</italic>3 and A prophages, we found significant (p&lt;0.05) associations between cGBS and C/GBS<italic>Int</italic>4 prophages, and between GBS from disease and prophages with integrase type GBS<italic>Int</italic>8.1 (<xref ref-type="fig" rid="F4">Figure 4</xref>). There were no significant differences in the prevalence of genomes lacking a prophage sequence, although a lower prophage content was observed in iiGBS (Supplementary Figure 5).</p><p id="P29">Our previous phylogenetic analysis of GBS prophages (<xref ref-type="bibr" rid="R36">36</xref>) revealed that 32/87 of type A prophages from Argentinian isolates were related to the type A prophages 12/111phiA and phiStag1, associated with CC17 virulence in infants (<xref ref-type="bibr" rid="R33">33</xref>,<xref ref-type="bibr" rid="R34">34</xref>,<xref ref-type="bibr" rid="R61">61</xref>). In this study we found that these prophages were rare in Argentinian CC17 (1/31, from a uGBS), most (20/32) were carried by 20/112 CC23/Ia isolates and only 1/32 belonged to a iiGBS.</p></sec><sec id="S11"><title>Presence of VDs and ARDs in the context of GBS epidemiology</title><p id="P30">We detected the presence of diverse known GBS VDs in all the isolates (n=468), including those involved in immune response evasion (IRE-VD), tissue damage (TD-VD) and adherence to host tissues and invasion (ATI-VD) (<xref ref-type="fig" rid="F3">Figure 3</xref>, for more details see Supplementary Figure 6). The results were in accordance with previous reports on VDs prevalence according to GBS lineage (see “Supplementary Results” in Supplementary Material 1).</p><p id="P31">Some genes presented different distributions when analysing VD presence according to Argentinian GBS collection. The <italic>hyl</italic>B gene had significantly (<italic>p</italic>&lt;0.001) lower prevalence in niGBS (4%) than in the other collections (over 84%), in accordance with the lower prevalence of lineage CC19/III in niGBS. The <italic>rib</italic> gene prevalence was significantly (<italic>p</italic>&lt;0.01) lower in niGBS (12%, against over 22% in the other collections), which was probably linked to the lower prevalence of serotype III isolates in that collection. The <italic>srtC3</italic> gene was found in a significantly (<italic>p</italic>&lt;0.01) higher proportion in isolates from invasive infections (92%) compared to those from urinary infections or colonisation (56% and 53%, respectively), and the pilus island PI-2b presented 15% prevalence in invasive GBS versus 32% and 28% in urinary or colonisation isolates, respectively. In the cases of <italic>srt</italic>C3 and PI-2b, no correlation was found between VD distribution and lineage prevalence in each collection.</p><p id="P32">ARDs to at least one antibiotic class were found in 90% (420/468) of the genomes (<xref ref-type="fig" rid="F3">Figure 3</xref>, for the detailed genes of each family see Supplementary Figure 6). All isolates presented the <italic>mre</italic>A gene (Macrolide efflux pump) (<xref ref-type="bibr" rid="R62">62</xref>), independently from Macrolides susceptibility, as previously described (<xref ref-type="bibr" rid="R63">63</xref>,<xref ref-type="bibr" rid="R64">64</xref>), so <italic>mre</italic>A was not considered an ARD in these results.</p><p id="P33">None of the VDs and ARDs detected based on gene databases used in this study were found in a prophage.</p></sec><sec id="S12"><title>ARDs to beta-lactam class</title><p id="P34">The majority of genomes (457/468) carried common PBP2x variants (1, 2, 4 and 5), not associated with reduced beta-lactam susceptibility (RBLS) (<xref ref-type="bibr" rid="R65">65</xref>). Variant 68 of PBP2x, which was previously reported as potentially associated with RBLS (<xref ref-type="bibr" rid="R65">65</xref>), was found in 2 Argentinian CC1/V uGBS isolates that were phenotypically susceptible to penicillin. PBP2x variants not previously described were found in 8/468 genomes, all from Argentinian GBS isolates susceptible to penicillin (<xref ref-type="table" rid="T1">Table 1</xref>). In one GBS genome from China, a PBP2x with a premature stop codon was found, but no data was available about beta-lactam susceptibility (<xref ref-type="table" rid="T1">Table 1</xref>).</p><p id="P35">Among Argentinian GBS, the uGBS isolates had a significantly (<italic>p</italic>&lt;0.01) higher prevalence of rare PBP-2x variants in comparison to other collections.</p></sec><sec id="S13"><title>ARDs to macrolide, lincosamide and streptogramin B (MLS) class</title><p id="P36">MLS resistance genes were found in 28% (131/468) of the genomes, mostly in lineages CC23/Ia, CC19/III and CC1/V (<xref ref-type="fig" rid="F3">Figure 3</xref>, Supplementary Figure 6). In the Argentinian isolates, their prevalence was 25% (92/365) and no significant difference was found in the content of these genes according to the collection category.</p><p id="P37">The presence of these genes was analysed in the context of their phenotypic susceptibility to MLS in the 365 Argentinian GBS. Concordance between the phenotypic resistance profile and the ARDs content was found in 97% (354/365) of the isolates. The discrepancies found in the remaining 11/365 genomes are detailed in Supplementary Material 1.</p></sec><sec id="S14"><title>ARDs to aminoglycoside class</title><p id="P38">ARDs to aminoglycosides were found in 18% (82/468) of the genomes, predominantly in CC19/III and CC23/Ia (<xref ref-type="fig" rid="F3">Figure 3</xref>, Supplementary Figure 6). In the Argentinian genomes, their prevalence was of 20% (71/365), with a significantly higher (<italic>p</italic>&lt;0.01) frequency in uGBS isolates, while niGBS showed a significantly lower prevalence (<italic>p</italic>&lt;0.01).</p><p id="P39">Phenotypic susceptibility to streptomycin (STR) and gentamicin (GEN) had been tested for 135 sequenced Argentinian invasive GBS isolates (both from infants and non-infants) (<xref ref-type="bibr" rid="R4">4</xref>) and concordance with genotypic profiles was found in 99% (133/135) of the isolates. The discrepancies found in the remaining 2/135 genomes are detailed in Supplementary Material 1.</p></sec><sec id="S15"><title>ARDs to quinolone class</title><p id="P40">Point mutations in the quinolone resistance-determining regions (QRDR) of genes <italic>gyr</italic>A and/or <italic>par</italic>C were found in 11% (51/468) of the genomes, most belonging to CC12/Ib and CC19/III. In Argentinian GBS the prevalence was 12% (45/365) and no significant difference was found in the presence of these ARDsby collection. The association between fluoroquinolone resistance and the clonal expansion of ST10/Ib GBS in Argentina was reported in our previous work (<xref ref-type="bibr" rid="R3">3</xref>).</p><p id="P41">Concordance was observed between the phenotypic quinolone-susceptibility profile (<xref ref-type="bibr" rid="R3">3</xref>,<xref ref-type="bibr" rid="R4">4</xref>) and the bioinformatic detection of point mutations in the <italic>gyr</italic>A and/or <italic>par</italic>C genes in 97% (355/365) of Argentinian GBS. The discrepancies found in the remaining 10/365 genomes are detailed in Supplementary Material 1.</p></sec><sec id="S16"><title>ARDs to other antibiotic classes</title><p id="P42">More than 77% of the genomes (365/468; 282/365) carried genes that confer resistance to tetracyclines. The frequency of these genes in the prevalent lineages was higher than 80%, with the exception of CC12/Ib (only present in 43% of the isolates) and CC23/II (no carriage of <italic>tet</italic> genes). High prevalence of <italic>tet</italic> genes is to be expected in GBS isolates, which is why tetracyclines are no longer used for human treatment nor are phenotypically tested for resistance (<xref ref-type="bibr" rid="R63">63</xref>).</p><p id="P43">No ARDs to vancomycin were found in the Argentinian isolates, in accordance with the phenotypic susceptibility previously determined for uGBS and cGBS (<xref ref-type="bibr" rid="R4">4</xref>,<xref ref-type="bibr" rid="R5">5</xref>). ARDs to vancomycin were only found in 2/468 previously described GBS from the USA (<xref ref-type="bibr" rid="R66">66</xref>).</p><p id="P44">Less than 10% of isolates carried ARDs to antibiotic classes not used for treatment of GBS infections in humans, thus not phenotypically tested in the Argentinian isolates: streptothricin (27/468), chloramphenicol (25/468) and trimethoprim (1/468).</p></sec><sec id="S17"><title>ARDs to multiple antibiotic classes</title><p id="P45">The presence of ARDs to three or more antibiotic classes was observed in 15% (71/468) of the genomes (Supplementary Figure 7), so they could be considered multi-drug resistant (MDR) isolates. These isolates belonged to CC19/III (30/71), followed by CC23/Ia (23/71), CC12/Ib (5/71) and CC17/III (4/71) (<xref ref-type="fig" rid="F5">Figure 5</xref>). Mutations in PBP2x potentially associated with RBLS and those not previously described were included in this analysis, as the accumulation of such mutations has been described as a risk factor for RBLS (<xref ref-type="bibr" rid="R56">56</xref>,<xref ref-type="bibr" rid="R67">67</xref>–<xref ref-type="bibr" rid="R69">69</xref>).</p><p id="P46">It is notable that ARDs to MLS were found in 70/71 isolates carrying ARDs to three or more antibiotic classes. Furthermore, of the 131 isolates with ARDs to MLS, 124 carried ARDs to at least one more antibiotic class, with ARDs to tetracyclines present in 116/124 of those isolates.</p><p id="P47">Among Argentinian isolates, uGBS carried a significantly (<italic>p</italic>&lt;0.01) higher proportion of ARDs to multiple antibiotic classes than the rest of collections (41% vs 18-30%, Supplementary Figure 7). A single isolate carried ARDs to 6 classes and represented CC19/III niGBS.</p></sec></sec><sec id="S18" sec-type="discussion"><title>Discussion</title><p id="P48">There are few studies describing the epidemiology of GBS isolated from humans in South America, and even fewer that report serotype or clonal complex distribution. The most recent data is from Brazil, where serotype Ia was reported as the most prevalent, followed by serotypes II or Ib, in maternal colonisation, infant disease, and invasive and non-invasive infections in non-pregnant adults (<xref ref-type="bibr" rid="R70">70</xref>–<xref ref-type="bibr" rid="R74">74</xref>). All Argentinian GBS collections analysed in this study presented CC23/Ia and CC12/Ib as the dominant lineages. Lineage prevalence distribution in South America contrasts with reports from other parts of the world, where there are different dominant lineages according to sample source. For example, the most prevalent lineage associated with infant invasive infections worldwide, except for South America, is CC17/III, while for infections in adults the most prevalent lineage tends to be CC1/V (<xref ref-type="bibr" rid="R75">75</xref>–<xref ref-type="bibr" rid="R77">77</xref>). In the case of maternal colonisation, there is more heterogeneity in the distribution of the dominant lineages according to the region of the world (<xref ref-type="bibr" rid="R78">78</xref>–<xref ref-type="bibr" rid="R80">80</xref>). For instance, in Europe and China the predominant lineage is CC19/III (<xref ref-type="bibr" rid="R81">81</xref>,<xref ref-type="bibr" rid="R82">82</xref>), in most African regions it is CC1/V (<xref ref-type="bibr" rid="R83">83</xref>), while in Australia it is CC23/Ia (<xref ref-type="bibr" rid="R84">84</xref>). In spite of the difference in lineage distribution, Argentinian isolates were found to be related to GBS from around the globe and to belong to both host-adapted and host-generalist lineages, as many of the prevalent lineages, specifically CC23/Ia, CC12/Ib and CC1/V, have been previously detected in animal species in different countries (<xref ref-type="bibr" rid="R85">85</xref>–<xref ref-type="bibr" rid="R87">87</xref>).</p><p id="P49">Surveillance of serotype distribution in each region is key to development of capsule polysaccharide-based GBS vaccines to estimate their possible coverage. In this regard, phenotypically non-typable (pNT) GBS isolates are a cause of concern, as the coverage of the serotype-specific vaccines is uncertain. In different parts of the world pNT GBS were reported in a range of 5-17% (17,19,88–93), while in Argentina only 3% (12/365) of isolates were pNT. In 1/12 of the Argentinian pNT isolates, only 2 genes of the <italic>cps</italic> operon were found, indicating a loss of the capsule (<xref ref-type="bibr" rid="R90">90</xref>,<xref ref-type="bibr" rid="R94">94</xref>). In another of the pNT isolates, all genes of the capsular type III were found, but <italic>cps</italic>J was shorter, which could have led to low or lack of capsule expression (<xref ref-type="bibr" rid="R90">90</xref>). In the remaining 10/12 pNT isolates, a capsular type could be assigned by genomic analysis, which could indicate sporadic errors in the phenotypic methods or a low or lack of expression of the capsular genes (<xref ref-type="bibr" rid="R95">95</xref>). Discrepancies between the capsular genotype and the phenotypic expression or errors in the interpretation of agglutination results can also be found in phenotypically typeable GBS, as was reported in 10-29% of isolates from different parts of the world (<xref ref-type="bibr" rid="R84">84</xref>,<xref ref-type="bibr" rid="R96">96</xref>,<xref ref-type="bibr" rid="R97">97</xref>). In Argentinian isolates, discrepancy of 15% was detected with no correlation between the capsular type and the differing serotype, so we believe that they might be due to random events and not something intrinsic to the <italic>cps</italic> loci sequence or its expression in one particular capsular type, nor systematic errors in the phenotypic detection method.</p><p id="P50">Two vaccines against GBS are currently in the final stages of clinical development. Pfizer is working on a hexavalent conjugate vaccine (GBS6) containing the capsular polysaccharides of serotypes Ia, Ib, II, III, IV and V (<xref ref-type="bibr" rid="R98">98</xref>). As this vaccine is aimed at pregnant women, it would cover an estimated 99% of maternal colonisation cases in Argentina and it could prevent 99% of infant infections. Applied to an adult general population, it could also help prevent 96% of invasive infections and 99% of urinary infections caused by GBS. Following a different approach, MinervaX has designed a recombinant protein vaccine (GBS-NN/NN2) based on the N-terminal domains of the prevalent surface proteins of the Alp family (AlpCN, RibN, Alp1N and Alp2/3N), thus avoiding concerns related to variations in GBS capsular type (<xref ref-type="bibr" rid="R99">99</xref>). The genes coding for one or more of these proteins were found in over 97% of Argentinian isolates, so a very high coverage would be expected also from this vaccine.</p><p id="P51">Over 71% of Argentinian isolates carried at least one prophage, which is consistent with previous reports on prophage content in GBS in different parts of the world (<xref ref-type="bibr" rid="R32">32</xref>,<xref ref-type="bibr" rid="R33">33</xref>,<xref ref-type="bibr" rid="R35">35</xref>,<xref ref-type="bibr" rid="R100">100</xref>,<xref ref-type="bibr" rid="R101">101</xref>). No significant differences were found in the total prophage prevalence based on collection type, though a lower prophage content was observed in GBS recovered from infant invasive infections. This lack of significant difference might be attributed to the low number of iiGBS recovered, a likely positive outcome of GBS prenatal screening being mandatory in Argentina. These results contrast with a study of GBS collections from France, where it was reported that isolates from disease carried more prophages than colonising isolates (<xref ref-type="bibr" rid="R32">32</xref>,<xref ref-type="bibr" rid="R102">102</xref>). This could be explained by differences in the prevalent GBS lineages in France and Argentina, since prophage content is associated with GBS lineage, and we found no significant differences in the lineage distribution among isolates from disease and colonisation.</p><p id="P52">While no virulence or antibiotic resistance determinants commonly found in GBS were carried by the prophages analysed in this study, these prophages do carry genes involved in bacterial fitness, host adaptation to stressful environments and virulence, and up to 60% of ORFs encoding proteins with unknown function, as reported in our previous study (<xref ref-type="bibr" rid="R36">36</xref>). Interestingly, the highest density of prophages, virulence and antibiotic resistance determinants was found in the CC19 isolates, mostly of capsular type III, independently from the origin of the isolates (disease or colonisation).</p><p id="P53">The prophages of type A 12/111phiA and phiStag1 had been reported to be associated with the clonal expansion of CC17 isolates causing severe infant infections in France (<xref ref-type="bibr" rid="R33">33</xref>,<xref ref-type="bibr" rid="R61">61</xref>) and the Netherlands (<xref ref-type="bibr" rid="R34">34</xref>), respectively. However, no evidence of clonal expansion related to the presence of these prophages were found in Argentinian isolates. Most GBS isolates carrying these prophages belonged to CC23/Ia, but they shared the same phylogenetic subclades as those without A prophages.</p><p id="P54">The presence of prophages with integrase type GBS<italic>Int</italic>8.1 or GBS<italic>Int</italic>8.2 in isolates recovered from disease but not from carriage, does not seem to be associated with a higher invasiveness of their host lineage, as they were found in a wide variety of GBS lineages. Instead, it could be linked to the carriage by all the prophages (15/15) of a gene with a Phox Homology (PX) domain (<xref ref-type="bibr" rid="R36">36</xref>), which is a phosphoinositide binding domain involved in protein-membrane and protein-protein interactions in eukaryotic cells (<xref ref-type="bibr" rid="R103">103</xref>,<xref ref-type="bibr" rid="R104">104</xref>). The PX domain was not found in any of the prophages carried by colonisation isolates, so it is possible that prophages encoding a protein with this domain give the host bacteria an advantage to invade the human body. GBS<italic>Int</italic>8 prophages also have in common their insertion between a transcriptional regulatory protein (YbaB/EbfC family) and a hypothetical protein (<xref ref-type="bibr" rid="R36">36</xref>,<xref ref-type="bibr" rid="R50">50</xref>). It remains to be investigated whether their insertion site might alter the expression of genes that are beneficial for host invasion. In any case, more isolates from disease and carriage need to be analysed to confirm that these prophages are exclusive to disease-causing isolates.</p><p id="P55">Phenotypic antibiotic resistance rates in our GBS collections were previously discussed (<xref ref-type="bibr" rid="R3">3</xref>,<xref ref-type="bibr" rid="R5">5</xref>,<xref ref-type="bibr" rid="R59">59</xref>). In more than 97% of our isolates, the presence of ARDs correlated with the phenotypic resistance determined for MLS, aminoglycosides and quinolones. This shows the high predictability potential for antibiotic resistance from whole genome sequence analyses. In the case of the mutations in <italic>pbp</italic>2x found in this study, their presence was not associated with RBLS, but it cannot be ruled out that they could be a risk factor for the generation of a PBP2x with lower affinity for these antibiotics in the event of a new mutation or selection pressure (<xref ref-type="bibr" rid="R69">69</xref>).</p><p id="P56">The frequency of isolates with multiple ARDs is worrisome, especially those with combined resistance to MLS, aminoglycosides and tetracyclines (almost 13% of the Argentinian isolates). The combination of tetracycline and macrolides resistance determinants has already been described two decades ago, and it was proposed that tetracycline-resistant isolates could play a role in the dissemination of macrolide-resistant strains, as both types of genes are usually found in the same mobile elements (<xref ref-type="bibr" rid="R63">63</xref>). It needs to be further investigated if the aminoglycoside ARDs in our isolates are co-carried on the same genetic elements, as described in <italic>Streptococcus pyogenes</italic> (<xref ref-type="bibr" rid="R105">105</xref>). High prevalence of multidrug-resistant CC19/III GBS has been previously described, mainly associated with fluoroquinolone-resistance, and presence of mobile genetic elements (MEGs) carrying multiple resistance determinants were reported (106-111). Further analysis of MEGs present in the Argentinian GBS genomes is warranted to investigate co-carriage of ARDs to multiple antibiotics, which might promote transmission of multidrug resistance in our population.</p><p id="P57">GBS isolated from urinary tract infections (UTI) had the highest frequency of resistance determinants to aminoglycosides and novel variants of <italic>pbp</italic>2x. Isolates containing ARDs to quinolones but susceptible to LEV and NOR were also found in this collection. These findings suggest that GBS colonising the urinary tract is subjected to increased selective pressure due to the exposure to beta-lactams, fluoroquinolones and aminoglycosides excreted in the urine (<xref ref-type="bibr" rid="R112">112</xref>–<xref ref-type="bibr" rid="R114">114</xref>) following their use for the treatment of different kinds of infections. This heightened selective pressure, combined with the accumulation of mutations associated with antibiotic resistance, could increase the risk of clinical treatment failure for UTIs caused by GBS.</p></sec><sec id="S19" sec-type="conclusions"><title>Conclusions</title><p id="P58">This is the first analysis of human-isolated GBS population based on whole genome sequence data in South America, with special focus on the analysis of prophage content. The findings in this study suggest a possible association between an increased GBS virulence and the carriage of prophages with integrase type GBS<italic>Int</italic>8 and/or the presence of genes that encode the Phox Homology domain. Given the high prevalence of the serotypes and relevant virulence factors that are targeted by the in-development GBS vaccines, we conclude that both would be highly effective in preventing infections in all age-groups affected by GBS in Argentina. Implementation of prevention strategies against GBS infections is crucial, especially in the context of the rising GBS resistance to multiple antibiotic classes. Given the lack of genomic epidemiology data from human-isolated GBS in South America, this study makes a significant contribution to our understanding of the global GBS population structure.</p></sec></body><back><ack id="S20"><title>Acknowledgements</title><p>We would like to thank all 40 participating centers of the multicentric study, their microbiologists and infectious disease specialists, and everyone involved in the genome sequencing of our GBS collection at the sequence facilities of the Wellcome Sanger Institute and Instituto Malbrán.</p><sec id="S21"><title>Funding</title><p>This study was funded by grants from Universidad de Buenos Aires (UBACYT 20020190100189BA and UBACYT 20020170200303BA) to LB, from CONICET (11220150100692CO and 11220220100373CO) to MM, and The Bill and Melinda Gates Foundation (INV-010426) to SB.</p></sec></ack><fn-group><fn id="FN2" fn-type="conflict"><p id="P59"><bold>Conflict of Interest</bold></p><p id="P60">The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></fn><fn id="FN3"><p id="P61"><bold>Ethical approval</bold></p><p id="P62">Ethical approval for the “Argentinian multicentric study on infections due to Streptococcus agalactiae” was provided by the Ethics Committee of the Faculty of Pharmacy and Biochemistry, University of Buenos Aires, Res [D] RESCD-2022-400-E-UBA-DCT.</p></fn><fn id="FN4" fn-type="con"><p id="P63"><bold>Author Contributions</bold></p><p id="P64">VK, SDG, MM and LB conceived this study and LB supervised it. TP, JC, UBK, DJ and SB conducted and coordinated the whole genome sequencing. VK and SDG designed the bioinformatic analyses. VK, MP and SDG performed the acquisition of the data. VK and SDG conducted the data analysis. SDG guided and supervised the bioinformatic analysis. CC participated in the discussion of the results and gave critical insights for their analysis. VK wrote the original draft of the manuscript. All authors reviewed, edited and approved the final version of the manuscript.</p></fn></fn-group><ref-list><ref id="R1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brokaw</surname><given-names>A</given-names></name><name><surname>Furuta</surname><given-names>A</given-names></name><name><surname>Dacanay</surname><given-names>M</given-names></name><name><surname>Rajagopal</surname><given-names>L</given-names></name><name><surname>Adams Waldorf</surname><given-names>KM</given-names></name></person-group><article-title>Bacterial and Host Determinants of Group B Streptococcal Vaginal Colonization and Ascending Infection in Pregnancy</article-title><source>Front Cell Infect Microbiol</source><year>2021</year><month>Sep</month><day>3</day><volume>11</volume><elocation-id>720789</elocation-id><pub-id pub-id-type="pmcid">PMC8446444</pub-id><pub-id pub-id-type="pmid">34540718</pub-id><pub-id pub-id-type="doi">10.3389/fcimb.2021.720789</pub-id></element-citation></ref><ref id="R2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martins</surname><given-names>ER</given-names></name><name><surname>Pedroso-Roussado</surname><given-names>C</given-names></name><name><surname>Melo-Cristino</surname><given-names>J</given-names></name><name><surname>Ramirez</surname><given-names>M</given-names></name><collab>The Portuguese Group for the Study of Streptococcal Infections</collab></person-group><article-title>Streptococcus agalactiae Causing Neonatal Infections in Portugal (2005–2015): Diversification and Emergence of a CC17/PI-2b Multidrug Resistant Sublineage</article-title><source>Front Microbiol</source><year>2017</year><month>Mar</month><day>28</day><fpage>8</fpage><date-in-citation>cited 2022 Dec 27</date-in-citation><comment>[Internet] Available from: <ext-link ext-link-type="uri" xlink:href="http://journal.frontiersin.org/article/10.3389/fmicb.2017.00499/full">http://journal.frontiersin.org/article/10.3389/fmicb.2017.00499/full</ext-link></comment><pub-id pub-id-type="pmcid">PMC5368217</pub-id><pub-id pub-id-type="pmid">28400757</pub-id><pub-id pub-id-type="doi">10.3389/fmicb.2017.00499</pub-id></element-citation></ref><ref id="R3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arias</surname><given-names>B</given-names></name><name><surname>Kovacec</surname><given-names>V</given-names></name><name><surname>Vigliarolo</surname><given-names>L</given-names></name><name><surname>Suárez</surname><given-names>M</given-names></name><name><surname>Tersigni</surname><given-names>C</given-names></name><name><surname>Müller</surname><given-names>L</given-names></name><etal/></person-group><article-title>Fluoroquinolone-Resistant <italic>Streptococcus agalactiae</italic> Invasive Isolates Recovered in Argentina</article-title><source>Microbial Drug Resistance</source><year>2019</year><month>Jun</month><volume>25</volume><issue>5</issue><fpage>739</fpage><lpage>43</lpage><pub-id pub-id-type="pmid">30676886</pub-id></element-citation></ref><ref id="R4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arias</surname><given-names>B</given-names></name><name><surname>Kovacec</surname><given-names>V</given-names></name><name><surname>Vigliarolo</surname><given-names>L</given-names></name><name><surname>Suárez</surname><given-names>M</given-names></name><name><surname>Tersigni</surname><given-names>C</given-names></name><name><surname>Lopardo</surname><given-names>H</given-names></name><etal/></person-group><article-title>Epidemiology of Invasive Infections Caused by <italic>Streptococcus agalactiae</italic> in Argentina</article-title><source>Microbial Drug Resistance</source><year>2022</year><month>Jan</month><day>10</day><elocation-id>mdr.2021.0071</elocation-id><pub-id pub-id-type="pmid">35007436</pub-id></element-citation></ref><ref id="R5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vigliarolo</surname><given-names>L</given-names></name><name><surname>Arias</surname><given-names>B</given-names></name><name><surname>Suárez</surname><given-names>M</given-names></name><name><surname>Van Haute</surname><given-names>E</given-names></name><name><surname>Kovacec</surname><given-names>V</given-names></name><name><surname>Lopardo</surname><given-names>H</given-names></name><etal/></person-group><article-title>Argentinian multicenter study on urinary tract infections due to Streptococcus agalactiae in adult patients</article-title><source>J Infect Dev Ctries</source><year>2019</year><month>Jan</month><day>31</day><volume>13</volume><issue>01</issue><fpage>77</fpage><lpage>82</lpage><pub-id pub-id-type="pmid">32032027</pub-id></element-citation></ref><ref id="R6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hayes</surname><given-names>K</given-names></name><name><surname>O’Halloran</surname><given-names>F</given-names></name><name><surname>Cotter</surname><given-names>L</given-names></name></person-group><article-title>A review of antibiotic resistance in Group B Streptococcus: the story so far</article-title><source>Critical Reviews in Microbiology</source><year>2020</year><month>May</month><day>3</day><volume>46</volume><issue>3</issue><fpage>253</fpage><lpage>69</lpage><pub-id pub-id-type="pmid">32363979</pub-id></element-citation></ref><ref id="R7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Navarro-Torné</surname><given-names>A</given-names></name><name><surname>Curcio</surname><given-names>D</given-names></name><name><surname>Moïsi</surname><given-names>JC</given-names></name><name><surname>Jodar</surname><given-names>L</given-names></name></person-group><article-title>Burden of invasive group B Streptococcus disease in non-pregnant adults: A systematic review and meta-analysis</article-title><person-group person-group-type="editor"><name><surname>Melo-Cristino</surname><given-names>J</given-names></name></person-group><source>PLoS ONE</source><year>2021</year><month>Sep</month><day>30</day><volume>16</volume><issue>9</issue><elocation-id>e0258030</elocation-id><pub-id pub-id-type="pmcid">PMC8483371</pub-id><pub-id pub-id-type="pmid">34591924</pub-id><pub-id pub-id-type="doi">10.1371/journal.pone.0258030</pub-id></element-citation></ref><ref id="R8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koide</surname><given-names>S</given-names></name><name><surname>Nagano</surname><given-names>Y</given-names></name><name><surname>Takizawa</surname><given-names>S</given-names></name><name><surname>Sakaguchi</surname><given-names>K</given-names></name><name><surname>Soga</surname><given-names>E</given-names></name><name><surname>Hayashi</surname><given-names>W</given-names></name><etal/></person-group><article-title>Genomic Traits Associated with Virulence and Antimicrobial Resistance of Invasive Group B Streptococcus Isolates with Reduced Penicillin Susceptibility from Elderly Adults</article-title><person-group person-group-type="editor"><name><surname>Doucet-Populaire</surname><given-names>FC</given-names></name></person-group><source>Microbiol Spectr</source><year>2022</year><month>Jun</month><day>29</day><volume>10</volume><issue>3</issue><elocation-id>e00568-22</elocation-id><pub-id pub-id-type="pmcid">PMC9241772</pub-id><pub-id pub-id-type="pmid">35639001</pub-id><pub-id pub-id-type="doi">10.1128/spectrum.00568-22</pub-id></element-citation></ref><ref id="R9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blancas</surname><given-names>D</given-names></name><name><surname>Santin</surname><given-names>M</given-names></name><name><surname>Olmo</surname><given-names>M</given-names></name><name><surname>Alcaide</surname><given-names>F</given-names></name><name><surname>Carratala</surname><given-names>J</given-names></name><name><surname>Gudiol</surname><given-names>F</given-names></name></person-group><article-title>Group B Streptococcal Disease in Nonpregnant Adults: Incidence, Clinical Characteristics, and Outcome</article-title><source>European Journal of Clinical Microbiology &amp; Infectious Diseases</source><year>2004</year><month>Mar</month><day>1</day><volume>23</volume><issue>3</issue><fpage>168</fpage><lpage>73</lpage><pub-id pub-id-type="pmid">14986167</pub-id></element-citation></ref><ref id="R10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pitts</surname><given-names>SI</given-names></name><name><surname>Maruthur</surname><given-names>NM</given-names></name><name><surname>Langley</surname><given-names>GE</given-names></name><name><surname>Pondo</surname><given-names>T</given-names></name><name><surname>Shutt</surname><given-names>KA</given-names></name><name><surname>Hollick</surname><given-names>R</given-names></name><etal/></person-group><article-title>Obesity, Diabetes, and the Risk of Invasive Group B Streptococcal Disease in Nonpregnant Adults in the United States</article-title><source>Open Forum Infectious Diseases</source><year>2018</year><month>Jun</month><day>1</day><volume>5</volume><issue>6</issue><elocation-id>ofy030</elocation-id><pub-id pub-id-type="pmcid">PMC6016410</pub-id><pub-id pub-id-type="pmid">29977953</pub-id><pub-id pub-id-type="doi">10.1093/ofid/ofy030</pub-id></element-citation></ref><ref id="R11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fuchs</surname><given-names>A</given-names></name><name><surname>Bielicki</surname><given-names>J</given-names></name><name><surname>Mathur</surname><given-names>S</given-names></name><name><surname>Sharland</surname><given-names>M</given-names></name><name><surname>Van Den Anker</surname><given-names>JN</given-names></name></person-group><article-title>Reviewing the WHO guidelines for antibiotic use for sepsis in neonates and children</article-title><source>Paediatrics and International Child Health</source><year>2018</year><month>Dec</month><day>21</day><volume>38</volume><issue>sup1</issue><fpage>S3</fpage><lpage>15</lpage><pub-id pub-id-type="pmcid">PMC6176768</pub-id><pub-id pub-id-type="pmid">29790842</pub-id><pub-id pub-id-type="doi">10.1080/20469047.2017.1408738</pub-id></element-citation></ref><ref id="R12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Russell</surname><given-names>NJ</given-names></name><name><surname>Stöhr</surname><given-names>W</given-names></name><name><surname>Plakkal</surname><given-names>N</given-names></name><name><surname>Cook</surname><given-names>A</given-names></name><name><surname>Berkley</surname><given-names>JA</given-names></name><name><surname>Adhisivam</surname><given-names>B</given-names></name><etal/></person-group><article-title>Patterns of antibiotic use, pathogens, and prediction of mortality in hospitalized neonates and young infants with sepsis: A global neonatal sepsis observational cohort study (NeoOBS)</article-title><source>PLoS Med</source><year>2023</year><month>Jun</month><day>8</day><volume>20</volume><issue>6</issue><elocation-id>e1004179</elocation-id><pub-id pub-id-type="pmcid">PMC10249878</pub-id><pub-id pub-id-type="pmid">37289666</pub-id><pub-id pub-id-type="doi">10.1371/journal.pmed.1004179</pub-id></element-citation></ref><ref id="R13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blaschke</surname><given-names>AJ</given-names></name><name><surname>Pulver</surname><given-names>LS</given-names></name><name><surname>Korgenski</surname><given-names>EK</given-names></name><name><surname>Savitz</surname><given-names>LA</given-names></name><name><surname>Daly</surname><given-names>JA</given-names></name><name><surname>Byington</surname><given-names>CL</given-names></name></person-group><article-title>Clindamycin-Resistant Group B Streptococcus and Failure of Intrapartum Prophylaxis to Prevent Early-Onset Disease</article-title><source>The Journal of Pediatrics</source><year>2010</year><month>Mar</month><volume>156</volume><issue>3</issue><fpage>501</fpage><lpage>3</lpage><pub-id pub-id-type="pmcid">PMC3153078</pub-id><pub-id pub-id-type="pmid">20056242</pub-id><pub-id pub-id-type="doi">10.1016/j.jpeds.2009.10.048</pub-id></element-citation></ref><ref id="R14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Snider</surname><given-names>JB</given-names></name><name><surname>Mithal</surname><given-names>LB</given-names></name><name><surname>Kwah</surname><given-names>JH</given-names></name><name><surname>Rhodes</surname><given-names>NJ</given-names></name><name><surname>Son</surname><given-names>M</given-names></name></person-group><article-title>Antibiotic choice for Group B Streptococcus prophylaxis in mothers with reported penicillin allergy and associated newborn outcomes</article-title><source>BMC Pregnancy Childbirth</source><year>2023</year><month>May</month><day>30</day><volume>23</volume><issue>1</issue><fpage>400</fpage><pub-id pub-id-type="pmcid">PMC10228028</pub-id><pub-id pub-id-type="pmid">37254067</pub-id><pub-id pub-id-type="doi">10.1186/s12884-023-05697-0</pub-id></element-citation></ref><ref id="R15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raabe</surname><given-names>VN</given-names></name><name><surname>Shane</surname><given-names>AL</given-names></name></person-group><article-title>Group B <italic>Streptococcus</italic> (<italic>Streptococcus agalactiae</italic>)</article-title><person-group person-group-type="editor"><name><surname>Fischetti</surname><given-names>VA</given-names></name><name><surname>Novick</surname><given-names>RP</given-names></name><name><surname>Ferretti</surname><given-names>JJ</given-names></name><name><surname>Portnoy</surname><given-names>DA</given-names></name><name><surname>Rood</surname><given-names>JI</given-names></name></person-group><source>Microbiol Spectr</source><year>2019</year><month>Apr</month><day>12</day><volume>7</volume><issue>2</issue><elocation-id>7.2.17</elocation-id><pub-id pub-id-type="pmcid">PMC6432937</pub-id><pub-id pub-id-type="pmid">30900541</pub-id><pub-id pub-id-type="doi">10.1128/microbiolspec.gpp3-0007-2018</pub-id></element-citation></ref><ref id="R16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Castor</surname><given-names>ML</given-names></name><name><surname>Whitney</surname><given-names>CG</given-names></name><name><surname>Como-Sabetti</surname><given-names>K</given-names></name><name><surname>Facklam</surname><given-names>RR</given-names></name><name><surname>Ferrieri</surname><given-names>P</given-names></name><name><surname>Bartkus</surname><given-names>JM</given-names></name><etal/></person-group><article-title>Antibiotic Resistance Patterns in Invasive Group B Streptococcal Isolates</article-title><source>Infectious Diseases in Obstetrics and Gynecology</source><year>2008</year><volume>2008</volume><fpage>1</fpage><lpage>5</lpage><pub-id pub-id-type="pmcid">PMC2637368</pub-id><pub-id pub-id-type="pmid">19223967</pub-id><pub-id pub-id-type="doi">10.1155/2008/727505</pub-id></element-citation></ref><ref id="R17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lamagni</surname><given-names>TL</given-names></name><name><surname>Keshishian</surname><given-names>C</given-names></name><name><surname>Efstratiou</surname><given-names>A</given-names></name><name><surname>Guy</surname><given-names>R</given-names></name><name><surname>Henderson</surname><given-names>KL</given-names></name><name><surname>Broughton</surname><given-names>K</given-names></name><etal/></person-group><article-title>Emerging Trends in the Epidemiology of Invasive Group B Streptococcal Disease in England and Wales, 1991–2010</article-title><source>Clinical Infectious Diseases</source><year>2013</year><month>Sep</month><day>1</day><volume>57</volume><issue>5</issue><fpage>682</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">23845950</pub-id></element-citation></ref><ref id="R18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Montilla</surname><given-names>A</given-names></name><name><surname>Zavala</surname><given-names>A</given-names></name><name><surname>Cáceres Cáceres</surname><given-names>R</given-names></name><name><surname>Cittadini</surname><given-names>R</given-names></name><name><surname>Vay</surname><given-names>C</given-names></name><name><surname>Gutkind</surname><given-names>G</given-names></name><etal/></person-group><article-title>Genetic Environment of the <italic>Inu</italic> (B) Gene in a Streptococcus agalactiae Clinical Isolate</article-title><source>Antimicrob Agents Chemother</source><year>2014</year><month>Sep</month><volume>58</volume><issue>9</issue><fpage>5636</fpage><lpage>7</lpage><pub-id pub-id-type="pmcid">PMC4135823</pub-id><pub-id pub-id-type="pmid">24957835</pub-id><pub-id pub-id-type="doi">10.1128/AAC.02630-14</pub-id></element-citation></ref><ref id="R19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alhhazmi</surname><given-names>A</given-names></name><name><surname>Hurteau</surname><given-names>D</given-names></name><name><surname>Tyrrell</surname><given-names>GJ</given-names></name></person-group><article-title>Epidemiology of Invasive Group B Streptococcal Disease in Alberta, Canada, from 2003 to 2013</article-title><person-group person-group-type="editor"><name><surname>Carroll</surname><given-names>KC</given-names></name></person-group><source>J Clin Microbiol</source><year>2016</year><month>Jul</month><volume>54</volume><issue>7</issue><fpage>1774</fpage><lpage>81</lpage><pub-id pub-id-type="pmcid">PMC4922093</pub-id><pub-id pub-id-type="pmid">27098960</pub-id><pub-id pub-id-type="doi">10.1128/JCM.00355-16</pub-id></element-citation></ref><ref id="R20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lopes</surname><given-names>E</given-names></name><name><surname>Fernandes</surname><given-names>T</given-names></name><name><surname>Machado</surname><given-names>MP</given-names></name><name><surname>Carriço</surname><given-names>JA</given-names></name><name><surname>Melo-Cristino</surname><given-names>J</given-names></name><name><surname>Ramirez</surname><given-names>M</given-names></name><etal/></person-group><article-title>Increasing macrolide resistance among Streptococcus agalactiae causing invasive disease in non-pregnant adults was driven by a single capsular-transformed lineage, Portugal, 2009 to 2015</article-title><source>Eurosurveillance [Internet]</source><year>2018</year><month>May</month><day>24</day><volume>23</volume><issue>21</issue><date-in-citation>cited 2021 May 4</date-in-citation><comment>[Internet]</comment><pub-id pub-id-type="pmcid">PMC6152215</pub-id><pub-id pub-id-type="pmid">29845930</pub-id><pub-id pub-id-type="doi">10.2807/1560-7917.ES.2018.23.21.1700473</pub-id></element-citation></ref><ref id="R21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nagano</surname><given-names>N</given-names></name><name><surname>Nagano</surname><given-names>Y</given-names></name><name><surname>Toyama</surname><given-names>M</given-names></name><name><surname>Kimura</surname><given-names>K</given-names></name><name><surname>Tamura</surname><given-names>T</given-names></name><name><surname>Shibayama</surname><given-names>K</given-names></name><etal/></person-group><article-title>Nosocomial spread of multidrug-resistant group B streptococci with reduced penicillin susceptibility belonging to clonal complex 1</article-title><source>Journal of Antimicrobial Chemotherapy</source><year>2012</year><month>Apr</month><day>1</day><volume>67</volume><issue>4</issue><fpage>849</fpage><lpage>56</lpage><pub-id pub-id-type="pmid">22210756</pub-id></element-citation></ref><ref id="R22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Villar</surname><given-names>HE</given-names></name><name><surname>Jugo</surname><given-names>MB</given-names></name></person-group><article-title>Emergence of high-level resistance to gentamicin and streptomycin in Streptococcus agalactiae in Buenos Aires, Argentina</article-title><source>Rev Esp Quimioter</source><year>2013</year><month>Jun</month><volume>26</volume><issue>2</issue><fpage>112</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">23817648</pub-id></element-citation></ref><ref id="R23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>C</given-names></name><name><surname>Nichols</surname><given-names>M</given-names></name><name><surname>Schrag</surname><given-names>SJ</given-names></name></person-group><article-title>Two Cases of Invasive Vancomycin-Resistant Group B Streptococcus Infection</article-title><source>N Engl J Med</source><year>2014</year><month>Feb</month><day>27</day><volume>370</volume><issue>9</issue><fpage>885</fpage><lpage>6</lpage><pub-id pub-id-type="pmcid">PMC11299425</pub-id><pub-id pub-id-type="pmid">24571775</pub-id><pub-id pub-id-type="doi">10.1056/NEJMc1308504</pub-id></element-citation></ref><ref id="R24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Faccone</surname><given-names>D</given-names></name><name><surname>Guerriero</surname><given-names>L</given-names></name><name><surname>Méndez</surname><given-names>E</given-names></name><name><surname>Errecalde</surname><given-names>L</given-names></name><name><surname>Cano</surname><given-names>H</given-names></name><name><surname>Yoyas</surname><given-names>N</given-names></name><etal/></person-group><article-title>Fluoroquinolone-resistant Streptococcus agalactiae isolates from Argentina</article-title><source>Rev Argent Microbiol</source><year>2010</year><month>Sep</month><volume>42</volume><issue>3</issue><fpage>203</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">21180391</pub-id></element-citation></ref><ref id="R25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carreras-Abad</surname><given-names>C</given-names></name><name><surname>Ramkhelawon</surname><given-names>L</given-names></name><name><surname>Heath</surname><given-names>PT</given-names></name><name><surname>Le Doare</surname><given-names>K</given-names></name></person-group><article-title>A Vaccine Against Group B Streptococcus: Recent Advances</article-title><source>IDR</source><year>2020</year><month>Apr</month><volume>13</volume><fpage>1263</fpage><lpage>72</lpage><pub-id pub-id-type="pmcid">PMC7196769</pub-id><pub-id pub-id-type="pmid">32425562</pub-id><pub-id pub-id-type="doi">10.2147/IDR.S203454</pub-id></element-citation></ref><ref id="R26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Juhas</surname><given-names>M</given-names></name></person-group><article-title>Horizontal gene transfer in human pathogens</article-title><source>Critical Reviews in Microbiology</source><year>2015</year><month>Jan</month><day>2</day><volume>41</volume><issue>1</issue><fpage>101</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">23862575</pub-id></element-citation></ref><ref id="R27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davies</surname><given-names>EV</given-names></name><name><surname>Winstanley</surname><given-names>C</given-names></name><name><surname>Fothergill</surname><given-names>JL</given-names></name><name><surname>James</surname><given-names>CE</given-names></name></person-group><article-title>The role of temperate bacteriophages in bacterial infection</article-title><person-group person-group-type="editor"><name><surname>Millard</surname><given-names>A</given-names></name></person-group><source>FEMS Microbiology Letters</source><year>2016</year><month>Mar</month><volume>363</volume><issue>5</issue><elocation-id>fnw015</elocation-id><pub-id pub-id-type="pmid">26825679</pub-id></element-citation></ref><ref id="R28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khan</surname><given-names>A</given-names></name><name><surname>Wahl</surname><given-names>LM</given-names></name></person-group><article-title>Quantifying the forces that maintain prophages in bacterial genomes</article-title><source>Theoretical Population Biology</source><year>2020</year><month>Jun</month><volume>133</volume><fpage>168</fpage><lpage>79</lpage><pub-id pub-id-type="pmid">31758948</pub-id></element-citation></ref><ref id="R29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hayashi</surname><given-names>T</given-names></name></person-group><article-title>Complete Genome Sequence of Enterohemorrhagic Eschelichia coli O157:H7 and Genomic Comparison with a Laboratory Strain K-12</article-title><source>DNA Research</source><year>2001</year><month>Jan</month><day>1</day><volume>8</volume><issue>1</issue><fpage>11</fpage><lpage>22</lpage><pub-id pub-id-type="pmid">11258796</pub-id></element-citation></ref><ref id="R30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Winstanley</surname><given-names>C</given-names></name><name><surname>Langille</surname><given-names>MGI</given-names></name><name><surname>Fothergill</surname><given-names>JL</given-names></name><name><surname>Kukavica-Ibrulj</surname><given-names>I</given-names></name><name><surname>Paradis-Bleau</surname><given-names>C</given-names></name><name><surname>Sanschagrin</surname><given-names>F</given-names></name><etal/></person-group><article-title>Newly introduced genomic prophage islands are critical determinants of in vivo competitiveness in the Liverpool Epidemic Strain of Pseudomonas aeruginosa</article-title><source>Genome Research</source><year>2008</year><month>Oct</month><day>29</day><volume>19</volume><issue>1</issue><fpage>12</fpage><lpage>23</lpage><pub-id pub-id-type="pmcid">PMC2612960</pub-id><pub-id pub-id-type="pmid">19047519</pub-id><pub-id pub-id-type="doi">10.1101/gr.086082.108</pub-id></element-citation></ref><ref id="R31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Busby</surname><given-names>B</given-names></name><name><surname>Kristensen</surname><given-names>DM</given-names></name><name><surname>Koonin</surname><given-names>EV</given-names></name></person-group><article-title>Contribution of phage-derived genomic islands to the virulence of facultative bacterial pathogens: Genomics update</article-title><source>Environ Microbiol</source><year>2013</year><month>Feb</month><volume>15</volume><issue>2</issue><fpage>307</fpage><lpage>12</lpage><pub-id pub-id-type="pmcid">PMC5866053</pub-id><pub-id pub-id-type="pmid">23035931</pub-id><pub-id pub-id-type="doi">10.1111/j.1462-2920.2012.02886.x</pub-id></element-citation></ref><ref id="R32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van der Mee-Marquet</surname><given-names>N</given-names></name><name><surname>Diene</surname><given-names>SM</given-names></name><name><surname>Barbera</surname><given-names>L</given-names></name><name><surname>Courtier-Martinez</surname><given-names>L</given-names></name><name><surname>Lafont</surname><given-names>L</given-names></name><name><surname>Ouachée</surname><given-names>A</given-names></name><etal/></person-group><article-title>Analysis of the prophages carried by human infecting isolates provides new insight into the evolution of Group B Streptococcus species</article-title><source>Clinical Microbiology and Infection</source><year>2018</year><month>May</month><volume>24</volume><issue>5</issue><fpage>514</fpage><lpage>21</lpage><pub-id pub-id-type="pmid">28870726</pub-id></element-citation></ref><ref id="R33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Renard</surname><given-names>A</given-names></name><name><surname>Barbera</surname><given-names>L</given-names></name><name><surname>Courtier-Martinez</surname><given-names>L</given-names></name><name><surname>Dos Santos</surname><given-names>S</given-names></name><name><surname>Valentin</surname><given-names>AS</given-names></name><name><surname>Mereghetti</surname><given-names>L</given-names></name><etal/></person-group><article-title>phiD12-Like Livestock-Associated Prophages Are Associated With Novel Subpopulations of Streptococcus agalactiae Infecting Neonates</article-title><source>Front Cell Infect Microbiol</source><year>2019</year><month>May</month><day>28</day><volume>9</volume><fpage>166</fpage><pub-id pub-id-type="pmcid">PMC6546898</pub-id><pub-id pub-id-type="pmid">31192160</pub-id><pub-id pub-id-type="doi">10.3389/fcimb.2019.00166</pub-id></element-citation></ref><ref id="R34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jamrozy</surname><given-names>D</given-names></name><name><surname>Bijlsma</surname><given-names>MW</given-names></name><name><surname>de Goffau</surname><given-names>MC</given-names></name><name><surname>van de Beek</surname><given-names>D</given-names></name><name><surname>Kuijpers</surname><given-names>TW</given-names></name><name><surname>Parkhill</surname><given-names>J</given-names></name><etal/></person-group><article-title>Increasing incidence of group B streptococcus neonatal infections in the Netherlands is associated with clonal expansion of CC17 and CC23</article-title><source>Sci Rep</source><year>2020</year><month>Dec</month><volume>10</volume><issue>1</issue><elocation-id>9539</elocation-id><pub-id pub-id-type="pmcid">PMC7293262</pub-id><pub-id pub-id-type="pmid">32533007</pub-id><pub-id pub-id-type="doi">10.1038/s41598-020-66214-3</pub-id></element-citation></ref><ref id="R35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lichvariková</surname><given-names>A</given-names></name><name><surname>Soltys</surname><given-names>K</given-names></name><name><surname>Szemes</surname><given-names>T</given-names></name><name><surname>Slobodnikova</surname><given-names>L</given-names></name><name><surname>Bukovska</surname><given-names>G</given-names></name><name><surname>Turna</surname><given-names>J</given-names></name><etal/></person-group><article-title>Characterization of Clinical and Carrier Streptococcus agalactiae and Prophage Contribution to the Strain Variability</article-title><source>Viruses</source><year>2020</year><month>Nov</month><day>18</day><volume>12</volume><issue>11</issue><elocation-id>1323</elocation-id><pub-id pub-id-type="pmcid">PMC7698700</pub-id><pub-id pub-id-type="pmid">33217933</pub-id><pub-id pub-id-type="doi">10.3390/v12111323</pub-id></element-citation></ref><ref id="R36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kovacec</surname><given-names>V</given-names></name><name><surname>Di Gregorio</surname><given-names>S</given-names></name><name><surname>Pajon</surname><given-names>M</given-names></name><name><surname>Crestani</surname><given-names>C</given-names></name><name><surname>Poklepovich</surname><given-names>T</given-names></name><name><surname>Campos</surname><given-names>J</given-names></name><etal/></person-group><article-title>Revisiting typing systems for group B Streptococcus prophages: an application in prophage detection and classification in group B Streptococcus isolates from Argentina</article-title><source>Microbial Genomics</source><year>2024</year><month>Oct</month><day>17</day><volume>10</volume><issue>10</issue><date-in-citation>cited 2024 Oct 18</date-in-citation><comment>[Internet] Available from</comment><pub-id pub-id-type="pmcid">PMC11485964</pub-id><pub-id pub-id-type="pmid">39418095</pub-id><pub-id pub-id-type="doi">10.1099/mgen.0.001297</pub-id></element-citation></ref><ref id="R37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seemann</surname><given-names>T</given-names></name></person-group><article-title>Prokka: rapid prokaryotic genome annotation</article-title><source>Bioinformatics</source><year>2014</year><month>Jul</month><day>15</day><volume>30</volume><issue>14</issue><fpage>2068</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">24642063</pub-id></element-citation></ref><ref id="R38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Page</surname><given-names>AJ</given-names></name><name><surname>Cummins</surname><given-names>CA</given-names></name><name><surname>Hunt</surname><given-names>M</given-names></name><name><surname>Wong</surname><given-names>VK</given-names></name><name><surname>Reuter</surname><given-names>S</given-names></name><name><surname>Holden</surname><given-names>MTG</given-names></name><etal/></person-group><article-title>Roary: rapid large-scale prokaryote pan genome analysis</article-title><source>Bioinformatics</source><year>2015</year><month>Nov</month><day>15</day><volume>31</volume><issue>22</issue><fpage>3691</fpage><lpage>3</lpage><pub-id pub-id-type="pmcid">PMC4817141</pub-id><pub-id pub-id-type="pmid">26198102</pub-id><pub-id pub-id-type="doi">10.1093/bioinformatics/btv421</pub-id></element-citation></ref><ref id="R39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Page</surname><given-names>AJ</given-names></name><name><surname>Taylor</surname><given-names>B</given-names></name><name><surname>Delaney</surname><given-names>AJ</given-names></name><name><surname>Soares</surname><given-names>J</given-names></name><name><surname>Seemann</surname><given-names>T</given-names></name><name><surname>Keane</surname><given-names>JA</given-names></name><etal/></person-group><article-title>SNP-sites: rapid efficient extraction of SNPs from multi-FASTA alignments</article-title><source>Microbial Genomics</source><year>2016</year><month>Apr</month><day>29</day><volume>2</volume><issue>4</issue><date-in-citation>cited 2021 May 4</date-in-citation><comment>[Internet] Available from</comment><pub-id pub-id-type="pmcid">PMC5320690</pub-id><pub-id pub-id-type="pmid">28348851</pub-id><pub-id pub-id-type="doi">10.1099/mgen.0.000056</pub-id></element-citation></ref><ref id="R40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Minh</surname><given-names>BQ</given-names></name><name><surname>Schmidt</surname><given-names>HA</given-names></name><name><surname>Chernomor</surname><given-names>O</given-names></name><name><surname>Schrempf</surname><given-names>D</given-names></name><name><surname>Woodhams</surname><given-names>MD</given-names></name><name><surname>von Haeseler</surname><given-names>A</given-names></name><etal/></person-group><article-title>IQ-TREE 2: New Models and Efficient Methods for Phylogenetic Inference in the Genomic Era</article-title><person-group person-group-type="editor"><name><surname>Teeling</surname><given-names>E</given-names></name></person-group><source>Molecular Biology and Evolution</source><year>2020</year><month>May</month><day>1</day><volume>37</volume><issue>5</issue><fpage>1530</fpage><lpage>4</lpage><pub-id pub-id-type="pmcid">PMC7182206</pub-id><pub-id pub-id-type="pmid">32011700</pub-id><pub-id pub-id-type="doi">10.1093/molbev/msaa015</pub-id></element-citation></ref><ref id="R41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guindon</surname><given-names>S</given-names></name><name><surname>Dufayard</surname><given-names>JF</given-names></name><name><surname>Lefort</surname><given-names>V</given-names></name><name><surname>Anisimova</surname><given-names>M</given-names></name><name><surname>Hordijk</surname><given-names>W</given-names></name><name><surname>Gascuel</surname><given-names>O</given-names></name></person-group><article-title>New Algorithms and Methods to Estimate Maximum-Likelihood Phylogenies: Assessing the Performance of PhyML 3.0</article-title><source>Systematic Biology</source><year>2010</year><month>Mar</month><day>29</day><volume>59</volume><issue>3</issue><fpage>307</fpage><lpage>21</lpage><pub-id pub-id-type="pmid">20525638</pub-id></element-citation></ref><ref id="R42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Minh</surname><given-names>BQ</given-names></name><name><surname>Nguyen</surname><given-names>MAT</given-names></name><name><surname>von Haeseler</surname><given-names>A</given-names></name></person-group><article-title>Ultrafast Approximation for Phylogenetic Bootstrap</article-title><source>Molecular Biology and Evolution</source><year>2013</year><month>May</month><day>1</day><volume>30</volume><issue>5</issue><fpage>1188</fpage><lpage>95</lpage><pub-id pub-id-type="pmcid">PMC3670741</pub-id><pub-id pub-id-type="pmid">23418397</pub-id><pub-id pub-id-type="doi">10.1093/molbev/mst024</pub-id></element-citation></ref><ref id="R43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sheppard</surname><given-names>AE</given-names></name><name><surname>Vaughan</surname><given-names>A</given-names></name><name><surname>Jones</surname><given-names>N</given-names></name><name><surname>Turner</surname><given-names>P</given-names></name><name><surname>Turner</surname><given-names>C</given-names></name><name><surname>Efstratiou</surname><given-names>A</given-names></name><etal/></person-group><article-title>Capsular Typing Method for Streptococcus agalactiae Using Whole-Genome Sequence Data</article-title><person-group person-group-type="editor"><name><surname>Ledeboer</surname><given-names>NA</given-names></name></person-group><source>J Clin Microbiol</source><year>2016</year><month>May</month><volume>54</volume><issue>5</issue><fpage>1388</fpage><lpage>90</lpage><pub-id pub-id-type="pmcid">PMC4844738</pub-id><pub-id pub-id-type="pmid">26962081</pub-id><pub-id pub-id-type="doi">10.1128/JCM.03142-15</pub-id></element-citation></ref><ref id="R44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Breeding</surname><given-names>KM</given-names></name><name><surname>Ragipani</surname><given-names>B</given-names></name><name><surname>Lee</surname><given-names>KUD</given-names></name><name><surname>Malik</surname><given-names>M</given-names></name><name><surname>Randis</surname><given-names>TM</given-names></name><name><surname>Ratner</surname><given-names>AJ</given-names></name></person-group><article-title>Real-time PCR-based serotyping of Streptococcus agalactiae</article-title><source>Sci Rep</source><year>2016</year><month>Dec</month><volume>6</volume><issue>1</issue><elocation-id>38523</elocation-id><pub-id pub-id-type="pmcid">PMC5133537</pub-id><pub-id pub-id-type="pmid">27910939</pub-id><pub-id pub-id-type="doi">10.1038/srep38523</pub-id></element-citation></ref><ref id="R45"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Song</surname><given-names>JY</given-names></name><name><surname>Lim</surname><given-names>JH</given-names></name><name><surname>Lim</surname><given-names>S</given-names></name><name><surname>Yong</surname><given-names>Z</given-names></name><name><surname>Seo</surname><given-names>HS</given-names></name></person-group><article-title>Progress toward a group B streptococcal vaccine</article-title><source>Human Vaccines &amp; Immunotherapeutics</source><year>2018</year><month>Jul</month><day>11</day><fpage>1</fpage><lpage>13</lpage><pub-id pub-id-type="pmcid">PMC6314413</pub-id><pub-id pub-id-type="pmid">29995578</pub-id><pub-id pub-id-type="doi">10.1080/21645515.2018.1493326</pub-id></element-citation></ref><ref id="R46"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gilchrist</surname><given-names>CLM</given-names></name><name><surname>Chooi</surname><given-names>YH</given-names></name></person-group><article-title>clinker &amp; clustermap.js: automatic generation of gene cluster comparison figures</article-title><person-group person-group-type="editor"><name><surname>Robinson</surname><given-names>P</given-names></name></person-group><source>Bioinformatics</source><year>2021</year><month>Aug</month><day>25</day><volume>37</volume><issue>16</issue><fpage>2473</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">33459763</pub-id></element-citation></ref><ref id="R47"><label>47</label><element-citation publication-type="web"><person-group person-group-type="author"><name><surname>Seemann</surname><given-names>T</given-names></name></person-group><source>mlst Github</source><year>2016</year><comment><ext-link ext-link-type="uri" xlink:href="https://github.com/tseemann/mlst">https://github.com/tseemann/mlst</ext-link> [Internet]. Available from: https://github.com/tseemann/mlst</comment></element-citation></ref><ref id="R48"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jones</surname><given-names>N</given-names></name><name><surname>Bohnsack</surname><given-names>JF</given-names></name><name><surname>Takahashi</surname><given-names>S</given-names></name><name><surname>Oliver</surname><given-names>KA</given-names></name><name><surname>Chan</surname><given-names>MS</given-names></name><name><surname>Kunst</surname><given-names>F</given-names></name><etal/></person-group><article-title>Multilocus Sequence Typing System for Group B Streptococcus</article-title><source>J Clin Microbiol</source><year>2003</year><month>Jun</month><volume>41</volume><issue>6</issue><fpage>2530</fpage><lpage>6</lpage><pub-id pub-id-type="pmcid">PMC156480</pub-id><pub-id pub-id-type="pmid">12791877</pub-id><pub-id pub-id-type="doi">10.1128/JCM.41.6.2530-2536.2003</pub-id></element-citation></ref><ref id="R49"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jolley</surname><given-names>KA</given-names></name><name><surname>Bray</surname><given-names>JE</given-names></name><name><surname>Maiden</surname><given-names>MCJ</given-names></name></person-group><article-title>Open-access bacterial population genomics: BIGSdb software, the PubMLST.org website and their applications</article-title><source>Wellcome Open Res</source><year>2018</year><month>Sep</month><day>24</day><volume>3</volume><fpage>124</fpage><pub-id pub-id-type="pmcid">PMC6192448</pub-id><pub-id pub-id-type="pmid">30345391</pub-id><pub-id pub-id-type="doi">10.12688/wellcomeopenres.14826.1</pub-id></element-citation></ref><ref id="R50"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crestani</surname><given-names>C</given-names></name><name><surname>Forde</surname><given-names>TL</given-names></name><name><surname>Zadoks</surname><given-names>RN</given-names></name></person-group><article-title>Development and Application of a Prophage Integrase Typing Scheme for Group B Streptococcus</article-title><source>Front Microbiol</source><year>2020</year><month>Aug</month><day>31</day><volume>11</volume><elocation-id>1993</elocation-id><pub-id pub-id-type="pmcid">PMC7487436</pub-id><pub-id pub-id-type="pmid">32983017</pub-id><pub-id pub-id-type="doi">10.3389/fmicb.2020.01993</pub-id></element-citation></ref><ref id="R51"><label>51</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Seemann</surname><given-names>T</given-names></name></person-group><source>Abricate</source><publisher-name>Github</publisher-name><year>2020</year><comment><ext-link ext-link-type="uri" xlink:href="https://github.com/tseemann/abricate">https://github.com/tseemann/abricate</ext-link></comment></element-citation></ref><ref id="R52"><label>52</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Zheng</surname><given-names>D</given-names></name><name><surname>Liu</surname><given-names>B</given-names></name><name><surname>Yang</surname><given-names>J</given-names></name><name><surname>Jin</surname><given-names>Q</given-names></name></person-group><article-title>VFDB 2016: hierarchical and refined dataset for big data analysis—10 years on</article-title><source>Nucleic Acids Res</source><year>2016</year><month>Jan</month><day>4</day><volume>44</volume><issue>D1</issue><fpage>D694</fpage><lpage>7</lpage><pub-id pub-id-type="pmcid">PMC4702877</pub-id><pub-id pub-id-type="pmid">26578559</pub-id><pub-id pub-id-type="doi">10.1093/nar/gkv1239</pub-id></element-citation></ref><ref id="R53"><label>53</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Metcalf</surname><given-names>BJ</given-names></name></person-group><source>GBS Surface Gene Database</source><publisher-name>github</publisher-name><year>2019</year><comment>[Internet] Available from: <ext-link ext-link-type="uri" xlink:href="https://github.com/BenJamesMetcalf/GBS_Scripts_Reference/blob/master/GBS_Reference_DB/GBS_Surface_Gene-DB_Final.fasta">https://github.com/BenJamesMetcalf/GBS_Scripts_Reference/blob/master/GBS_Reference_DB/GBS_Surface_Gene-DB_Final.fasta</ext-link></comment></element-citation></ref><ref id="R54"><label>54</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zankari</surname><given-names>E</given-names></name><name><surname>Hasman</surname><given-names>H</given-names></name><name><surname>Cosentino</surname><given-names>S</given-names></name><name><surname>Vestergaard</surname><given-names>M</given-names></name><name><surname>Rasmussen</surname><given-names>S</given-names></name><name><surname>Lund</surname><given-names>O</given-names></name><etal/></person-group><article-title>Identification of acquired antimicrobial resistance genes</article-title><source>Journal of Antimicrobial Chemotherapy</source><year>2012</year><month>Nov</month><day>1</day><volume>67</volume><issue>11</issue><fpage>2640</fpage><lpage>4</lpage><pub-id pub-id-type="pmcid">PMC3468078</pub-id><pub-id pub-id-type="pmid">22782487</pub-id><pub-id pub-id-type="doi">10.1093/jac/dks261</pub-id></element-citation></ref><ref id="R55"><label>55</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feldgarden</surname><given-names>M</given-names></name><name><surname>Brover</surname><given-names>V</given-names></name><name><surname>Gonzalez-Escalona</surname><given-names>N</given-names></name><name><surname>Frye</surname><given-names>JG</given-names></name><name><surname>Haendiges</surname><given-names>J</given-names></name><name><surname>Haft</surname><given-names>DH</given-names></name><etal/></person-group><article-title>AMRFinderPlus and the Reference Gene Catalog facilitate examination of the genomic links among antimicrobial resistance, stress response, and virulence</article-title><source>Sci Rep</source><year>2021</year><month>Jun</month><day>16</day><volume>11</volume><issue>1</issue><elocation-id>12728</elocation-id><pub-id pub-id-type="pmcid">PMC8208984</pub-id><pub-id pub-id-type="pmid">34135355</pub-id><pub-id pub-id-type="doi">10.1038/s41598-021-91456-0</pub-id></element-citation></ref><ref id="R56"><label>56</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Metcalf</surname><given-names>BJ</given-names></name><name><surname>Chochua</surname><given-names>S</given-names></name><name><surname>Gertz</surname><given-names>RE</given-names></name><name><surname>Hawkins</surname><given-names>PA</given-names></name><name><surname>Ricaldi</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>Z</given-names></name><etal/></person-group><article-title>Short-read whole genome sequencing for determination of antimicrobial resistance mechanisms and capsular serotypes of current invasive Streptococcus agalactiae recovered in the USA</article-title><source>Clinical Microbiology and Infection</source><year>2017</year><month>Aug</month><volume>23</volume><issue>8</issue><elocation-id>574.e7-574.e14</elocation-id><pub-id pub-id-type="pmid">28257899</pub-id></element-citation></ref><ref id="R57"><label>57</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Metcalf</surname><given-names>BJ</given-names></name></person-group><source>GBS bLactam 2X Database</source><publisher-name>github</publisher-name><year>2021</year><comment>[Internet] Available from: <ext-link ext-link-type="uri" xlink:href="https://github.com/BenJamesMetcalf/GBS_Scripts_Reference/blob/master/GBS_Reference_DB/GBS_bLactam_2X-DB.faa">https://github.com/BenJamesMetcalf/GBS_Scripts_Reference/blob/master/GBS_Reference_DB/GBS_bLactam_2X-DB.faa</ext-link></comment></element-citation></ref><ref id="R58"><label>58</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Metcalf</surname><given-names>BJ</given-names></name></person-group><source>GBS Resistance Gene Database</source><publisher-name>github</publisher-name><year>2020</year><comment>[Internet] Available from: <ext-link ext-link-type="uri" xlink:href="https://github.com/BenJamesMetcalf/GBS_Scripts_Reference/blob/master/GBS_Reference_DB/GBS_Res_Gene-DB_Final.fasta">https://github.com/BenJamesMetcalf/GBS_Scripts_Reference/blob/master/GBS_Reference_DB/GBS_Res_Gene-DB_Final.fasta</ext-link></comment></element-citation></ref><ref id="R59"><label>59</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Arias</surname><given-names>B</given-names></name></person-group><source>Aspectos moleculares y epidemiológicos de las infecciones causadas por Streptococcus agalactiae</source><publisher-name>Tesis Doctoral, Universidad de Buenos Aires</publisher-name><publisher-loc>Buenos Aires, Argentina</publisher-loc><year>2022</year></element-citation></ref><ref id="R60"><label>60</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Argimón</surname><given-names>S</given-names></name><name><surname>Abudahab</surname><given-names>K</given-names></name><name><surname>Goater</surname><given-names>RJE</given-names></name><name><surname>Fedosejev</surname><given-names>A</given-names></name><name><surname>Bhai</surname><given-names>J</given-names></name><name><surname>Glasner</surname><given-names>C</given-names></name><etal/></person-group><article-title>Microreact: visualizing and sharing data for genomic epidemiology and phylogeography</article-title><source>Microbial Genomics</source><year>2016</year><month>Nov</month><day>30</day><volume>2</volume><issue>11</issue><date-in-citation>cited 2021 May 4</date-in-citation><comment>[Internet] Available from</comment><pub-id pub-id-type="pmcid">PMC5320705</pub-id><pub-id pub-id-type="pmid">28348833</pub-id><pub-id pub-id-type="doi">10.1099/mgen.0.000093</pub-id></element-citation></ref><ref id="R61"><label>61</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Renard</surname><given-names>A</given-names></name><name><surname>Diene</surname><given-names>SM</given-names></name><name><surname>Courtier-Martinez</surname><given-names>L</given-names></name><name><surname>Gaillard</surname><given-names>JB</given-names></name><name><surname>Gbaguidi-Haore</surname><given-names>H</given-names></name><name><surname>Mereghetti</surname><given-names>L</given-names></name><etal/></person-group><article-title>12/111phiA Prophage Domestication Is Associated with Autoaggregation and Increased Ability to Produce Biofilm in Streptococcus agalactiae</article-title><source>Microorganisms</source><year>2021</year><month>May</month><day>21</day><volume>9</volume><issue>6</issue><elocation-id>1112</elocation-id><pub-id pub-id-type="pmcid">PMC8223999</pub-id><pub-id pub-id-type="pmid">34063935</pub-id><pub-id pub-id-type="doi">10.3390/microorganisms9061112</pub-id></element-citation></ref><ref id="R62"><label>62</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clarebout</surname><given-names>G</given-names></name><name><surname>Villers</surname><given-names>C</given-names></name><name><surname>Leclercq</surname><given-names>R</given-names></name></person-group><article-title>Macrolide Resistance Gene <italic>mreA</italic> of <italic>Streptococcus agalactiae</italic> Encodes a Flavokinase</article-title><source>Antimicrob Agents Chemother</source><year>2001</year><month>Aug</month><volume>45</volume><issue>8</issue><fpage>2280</fpage><lpage>6</lpage><pub-id pub-id-type="pmcid">PMC90643</pub-id><pub-id pub-id-type="pmid">11451686</pub-id><pub-id pub-id-type="doi">10.1128/AAC.45.8.2280-2286.2001</pub-id></element-citation></ref><ref id="R63"><label>63</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duarte</surname><given-names>RS</given-names></name><name><surname>Bellei</surname><given-names>BC</given-names></name><name><surname>Miranda</surname><given-names>OP</given-names></name><name><surname>Brito</surname><given-names>MAVP</given-names></name><name><surname>Teixeira</surname><given-names>LM</given-names></name></person-group><article-title>Distribution of Antimicrobial Resistance and Virulence-Related Genes among Brazilian Group B Streptococci Recovered from Bovine and Human Sources</article-title><source>Antimicrob Agents Chemother</source><year>2005</year><month>Jan</month><volume>49</volume><issue>1</issue><fpage>97</fpage><lpage>103</lpage><pub-id pub-id-type="pmcid">PMC538850</pub-id><pub-id pub-id-type="pmid">15616281</pub-id><pub-id pub-id-type="doi">10.1128/AAC.49.1.97-103.2005</pub-id></element-citation></ref><ref id="R64"><label>64</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zeng</surname><given-names>X</given-names></name><name><surname>Kong</surname><given-names>F</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Darbar</surname><given-names>A</given-names></name><name><surname>Gilbert</surname><given-names>GL</given-names></name></person-group><article-title>Simultaneous Detection of Nine Antibiotic Resistance-Related Genes in <italic>Streptococcus agalactiae</italic> Using Multiplex PCR and Reverse Line Blot Hybridization Assay</article-title><source>Antimicrob Agents Chemother</source><year>2006</year><month>Jan</month><volume>50</volume><issue>1</issue><fpage>204</fpage><lpage>9</lpage><pub-id pub-id-type="pmcid">PMC1346803</pub-id><pub-id pub-id-type="pmid">16377687</pub-id><pub-id pub-id-type="doi">10.1128/AAC.50.1.204-209.2006</pub-id></element-citation></ref><ref id="R65"><label>65</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kobayashi</surname><given-names>M</given-names></name><name><surname>McGee</surname><given-names>L</given-names></name><name><surname>Chochua</surname><given-names>S</given-names></name><name><surname>Apostol</surname><given-names>M</given-names></name><name><surname>Alden</surname><given-names>NB</given-names></name><name><surname>Farley</surname><given-names>MM</given-names></name><etal/></person-group><article-title>Low but Increasing Prevalence of Reduced Beta-lactam Susceptibility Among Invasive Group B Streptococcal Isolates, US Population-Based Surveillance, 1998–2018</article-title><source>Open Forum Infectious Diseases</source><year>2021</year><month>Feb</month><day>1</day><volume>8</volume><issue>2</issue><elocation-id>ofaa634</elocation-id><pub-id pub-id-type="pmcid">PMC7850125</pub-id><pub-id pub-id-type="pmid">33553474</pub-id><pub-id pub-id-type="doi">10.1093/ofid/ofaa634</pub-id></element-citation></ref><ref id="R66"><label>66</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Srinivasan</surname><given-names>V</given-names></name><name><surname>Metcalf</surname><given-names>BJ</given-names></name><name><surname>Knipe</surname><given-names>KM</given-names></name><name><surname>Ouattara</surname><given-names>M</given-names></name><name><surname>McGee</surname><given-names>L</given-names></name><name><surname>Shewmaker</surname><given-names>PL</given-names></name><etal/></person-group><article-title><italic>vanG</italic> Element Insertions within a Conserved Chromosomal Site Conferring Vancomycin Resistance to Streptococcus agalactiae and Streptococcus anginosus</article-title><person-group person-group-type="editor"><name><surname>Hughes</surname><given-names>J</given-names></name></person-group><source>mBio</source><year>2014</year><month>Aug</month><day>29</day><volume>5</volume><issue>4</issue><elocation-id>e01386-14</elocation-id><pub-id pub-id-type="pmcid">PMC4120198</pub-id><pub-id pub-id-type="pmid">25053786</pub-id><pub-id pub-id-type="doi">10.1128/mBio.01386-14</pub-id></element-citation></ref><ref id="R67"><label>67</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nagano</surname><given-names>N</given-names></name><name><surname>Nagano</surname><given-names>Y</given-names></name><name><surname>Kimura</surname><given-names>K</given-names></name><name><surname>Tamai</surname><given-names>K</given-names></name><name><surname>Yanagisawa</surname><given-names>H</given-names></name><name><surname>Arakawa</surname><given-names>Y</given-names></name></person-group><article-title>Genetic Heterogeneity in <italic>pbp</italic> Genes among Clinically Isolated Group B Streptococci with Reduced Penicillin Susceptibility</article-title><source>Antimicrob Agents Chemother</source><year>2008</year><month>Dec</month><volume>52</volume><issue>12</issue><fpage>4258</fpage><lpage>67</lpage><pub-id pub-id-type="pmcid">PMC2592870</pub-id><pub-id pub-id-type="pmid">18809936</pub-id><pub-id pub-id-type="doi">10.1128/AAC.00596-08</pub-id></element-citation></ref><ref id="R68"><label>68</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kimura</surname><given-names>K</given-names></name><name><surname>Nagano</surname><given-names>N</given-names></name><name><surname>Arakawa</surname><given-names>Y</given-names></name></person-group><article-title>Classification of group B streptococci with reduced β-lactam susceptibility (GBS-RBS) based on the amino acid substitutions in PBPs</article-title><source>Journal of Antimicrobial Chemotherapy</source><year>2015</year><month>Jun</month><day>1</day><volume>70</volume><issue>6</issue><fpage>1601</fpage><lpage>3</lpage><pub-id pub-id-type="pmid">25667406</pub-id></element-citation></ref><ref id="R69"><label>69</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McGuire</surname><given-names>E</given-names></name><name><surname>Ready</surname><given-names>D</given-names></name><name><surname>Ellaby</surname><given-names>N</given-names></name><name><surname>Potterill</surname><given-names>I</given-names></name><name><surname>Pike</surname><given-names>R</given-names></name><name><surname>Hopkins</surname><given-names>KL</given-names></name><etal/></person-group><article-title>A case of penicillin-resistant group B <italic>Streptococcus</italic> isolated from a patient in the UK</article-title><source>Journal of Antimicrobial Chemotherapy</source><year>2024</year><month>Nov</month><day>15</day><elocation-id>dkae419</elocation-id><pub-id pub-id-type="pmid">39545469</pub-id></element-citation></ref><ref id="R70"><label>70</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Souza</surname><given-names>VC</given-names></name><name><surname>Kegele</surname><given-names>FCO</given-names></name><name><surname>Souza</surname><given-names>SR</given-names></name><name><surname>Neves</surname><given-names>FPG</given-names></name><name><surname>De Paula</surname><given-names>GR</given-names></name><name><surname>Barros</surname><given-names>RR</given-names></name></person-group><article-title>Antimicrobial susceptibility and genetic diversity of Streptococcus agalactiae recovered from newborns and pregnant women in Brazil</article-title><source>Scandinavian Journal of Infectious Diseases</source><year>2013</year><month>Oct</month><volume>45</volume><issue>10</issue><fpage>780</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">23876189</pub-id></element-citation></ref><ref id="R71"><label>71</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dutra</surname><given-names>VG</given-names></name><name><surname>Alves</surname><given-names>VM</given-names></name><name><surname>Olendzki</surname><given-names>AN</given-names></name><name><surname>Dias</surname><given-names>CA</given-names></name><name><surname>De Bastos</surname><given-names>AF</given-names></name><name><surname>Santos</surname><given-names>GO</given-names></name><etal/></person-group><article-title>Streptococcus agalactiae in Brazil: serotype distribution, virulence determinants and antimicrobial susceptibility</article-title><source>BMC Infect Dis</source><year>2014</year><month>Dec</month><volume>14</volume><issue>1</issue><fpage>323</fpage><pub-id pub-id-type="pmcid">PMC4061772</pub-id><pub-id pub-id-type="pmid">24919844</pub-id><pub-id pub-id-type="doi">10.1186/1471-2334-14-323</pub-id></element-citation></ref><ref id="R72"><label>72</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Botelho</surname><given-names>ACN</given-names></name><name><surname>Oliveira</surname><given-names>JG</given-names></name><name><surname>Damasco</surname><given-names>AP</given-names></name><name><surname>Santos</surname><given-names>KTB</given-names></name><name><surname>Ferreira</surname><given-names>AFM</given-names></name><name><surname>Rocha</surname><given-names>GT</given-names></name><etal/></person-group><article-title>Streptococcus agalactiae carriage among pregnant women living in Rio de Janeiro, Brazil, over a period of eight years</article-title><person-group person-group-type="editor"><name><surname>Melo-Cristino</surname><given-names>J</given-names></name></person-group><source>PLoS ONE</source><year>2018</year><month>May</month><day>11</day><volume>13</volume><issue>5</issue><elocation-id>e0196925</elocation-id><pub-id pub-id-type="pmcid">PMC5947911</pub-id><pub-id pub-id-type="pmid">29750801</pub-id><pub-id pub-id-type="doi">10.1371/journal.pone.0196925</pub-id></element-citation></ref><ref id="R73"><label>73</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Do Nascimento</surname><given-names>CS</given-names></name><name><surname>Dos Santos</surname><given-names>NFB</given-names></name><name><surname>Ferreira</surname><given-names>RCC</given-names></name><name><surname>Taddei</surname><given-names>CR</given-names></name></person-group><article-title>Streptococcus agalactiae in pregnant women in Brazil: prevalence, serotypes, and antibiotic resistance</article-title><source>Braz J Microbiol</source><year>2019</year><month>Oct</month><volume>50</volume><issue>4</issue><fpage>943</fpage><lpage>52</lpage><pub-id pub-id-type="pmcid">PMC6863207</pub-id><pub-id pub-id-type="pmid">31432465</pub-id><pub-id pub-id-type="doi">10.1007/s42770-019-00129-8</pub-id></element-citation></ref><ref id="R74"><label>74</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Figueiredo Sanches</surname><given-names>G</given-names></name><name><surname>Lannes-Costa</surname><given-names>PS</given-names></name><name><surname>Cristoforêto</surname><given-names>MC</given-names></name><name><surname>Doran</surname><given-names>KS</given-names></name><name><surname>Mattos-Guaraldi</surname><given-names>AL</given-names></name><name><surname>Nagao</surname><given-names>PE</given-names></name></person-group><article-title>Streptococcus agalactiae strains isolated from cancer patients in Rio de Janeiro, Brazil</article-title><source>Braz J Microbiol</source><year>2021</year><month>Mar</month><volume>52</volume><issue>1</issue><fpage>303</fpage><lpage>10</lpage><pub-id pub-id-type="pmcid">PMC7966615</pub-id><pub-id pub-id-type="pmid">33398672</pub-id><pub-id pub-id-type="doi">10.1007/s42770-020-00419-6</pub-id></element-citation></ref><ref id="R75"><label>75</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Madrid</surname><given-names>L</given-names></name><name><surname>Seale</surname><given-names>AC</given-names></name><name><surname>Kohli-Lynch</surname><given-names>M</given-names></name><name><surname>Edmond</surname><given-names>KM</given-names></name><name><surname>Lawn</surname><given-names>JE</given-names></name><name><surname>Heath</surname><given-names>PT</given-names></name><etal/></person-group><article-title>Infant Group B Streptococcal Disease Incidence and Serotypes Worldwide: Systematic Review and Meta-analyses</article-title><source>Clinical Infectious Diseases</source><year>2017</year><month>Nov</month><day>6</day><volume>65</volume><issue>suppl_2</issue><fpage>S160</fpage><lpage>72</lpage><pub-id pub-id-type="pmcid">PMC5850457</pub-id><pub-id pub-id-type="pmid">29117326</pub-id><pub-id pub-id-type="doi">10.1093/cid/cix656</pub-id></element-citation></ref><ref id="R76"><label>76</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bianchi-Jassir</surname><given-names>F</given-names></name><name><surname>Paul</surname><given-names>P</given-names></name><name><surname>To</surname><given-names>KN</given-names></name><name><surname>Carreras-Abad</surname><given-names>C</given-names></name><name><surname>Seale</surname><given-names>AC</given-names></name><name><surname>Jauneikaite</surname><given-names>E</given-names></name><etal/></person-group><article-title>Systematic review of Group B Streptococcal capsular types, sequence types and surface proteins as potential vaccine candidates</article-title><source>Vaccine</source><year>2020</year><month>Oct</month><volume>38</volume><issue>43</issue><fpage>6682</fpage><lpage>94</lpage><pub-id pub-id-type="pmcid">PMC7526974</pub-id><pub-id pub-id-type="pmid">32888741</pub-id><pub-id pub-id-type="doi">10.1016/j.vaccine.2020.08.052</pub-id></element-citation></ref><ref id="R77"><label>77</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Founou</surname><given-names>LL</given-names></name><name><surname>Khan</surname><given-names>UB</given-names></name><name><surname>Medugu</surname><given-names>N</given-names></name><name><surname>Pinto</surname><given-names>TCA</given-names></name><name><surname>Darboe</surname><given-names>S</given-names></name><name><surname>Chendi</surname><given-names>Z</given-names></name><etal/></person-group><article-title>Molecular epidemiology of Streptococcus agalactiae in non-pregnant populations: a systematic review</article-title><source>Microbial Genomics</source><year>2023</year><month>Nov</month><day>29</day><volume>9</volume><issue>11</issue><date-in-citation>cited 2024 Oct 24</date-in-citation><comment>[Internet] Available from</comment><pub-id pub-id-type="pmcid">PMC10711312</pub-id><pub-id pub-id-type="pmid">38019122</pub-id><pub-id pub-id-type="doi">10.1099/mgen.0.001140</pub-id></element-citation></ref><ref id="R78"><label>78</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hall</surname><given-names>J</given-names></name><name><surname>Adams</surname><given-names>NH</given-names></name><name><surname>Bartlett</surname><given-names>L</given-names></name><name><surname>Seale</surname><given-names>AC</given-names></name><name><surname>Lamagni</surname><given-names>T</given-names></name><name><surname>Bianchi-Jassir</surname><given-names>F</given-names></name><etal/></person-group><article-title>Maternal Disease With Group B Streptococcus and Serotype Distribution Worldwide: Systematic Review and Meta-analyses</article-title><source>Clinical Infectious Diseases</source><year>2017</year><month>Nov</month><day>6</day><volume>65</volume><issue>suppl_2</issue><fpage>S112</fpage><lpage>24</lpage><pub-id pub-id-type="pmcid">PMC5850000</pub-id><pub-id pub-id-type="pmid">29117328</pub-id><pub-id pub-id-type="doi">10.1093/cid/cix660</pub-id></element-citation></ref><ref id="R79"><label>79</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Russell</surname><given-names>NJ</given-names></name><name><surname>Seale</surname><given-names>AC</given-names></name><name><surname>O’Driscoll</surname><given-names>M</given-names></name><name><surname>O’Sullivan</surname><given-names>C</given-names></name><name><surname>Bianchi-Jassir</surname><given-names>F</given-names></name><name><surname>Gonzalez-Guarin</surname><given-names>J</given-names></name><etal/></person-group><article-title>Maternal Colonization With Group B Streptococcus and Serotype Distribution Worldwide: Systematic Review and Meta-analyses</article-title><source>Clinical Infectious Diseases</source><year>2017</year><month>Nov</month><day>6</day><volume>65</volume><issue>suppl_2</issue><fpage>S100</fpage><lpage>11</lpage><pub-id pub-id-type="pmcid">PMC5848259</pub-id><pub-id pub-id-type="pmid">29117327</pub-id><pub-id pub-id-type="doi">10.1093/cid/cix658</pub-id></element-citation></ref><ref id="R80"><label>80</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Furfaro</surname><given-names>LL</given-names></name><name><surname>Chang</surname><given-names>BJ</given-names></name><name><surname>Payne</surname><given-names>MS</given-names></name></person-group><article-title>Perinatal Streptococcus agalactiae Epidemiology and Surveillance Targets</article-title><source>Clin Microbiol Rev</source><year>2018</year><month>Oct</month><volume>31</volume><issue>4</issue><elocation-id>e00049-18</elocation-id><pub-id pub-id-type="pmcid">PMC6148196</pub-id><pub-id pub-id-type="pmid">30111577</pub-id><pub-id pub-id-type="doi">10.1128/CMR.00049-18</pub-id></element-citation></ref><ref id="R81"><label>81</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Lin</surname><given-names>M</given-names></name><name><surname>Bao</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>G</given-names></name><name><surname>Dong</surname><given-names>R</given-names></name><etal/></person-group><article-title>Maternal colonization with group B Streptococcus and antibiotic resistance in China: systematic review and meta-analyses</article-title><source>Ann Clin Microbiol Antimicrob</source><year>2023</year><month>Jan</month><day>13</day><volume>22</volume><issue>1</issue><fpage>5</fpage><pub-id pub-id-type="pmcid">PMC9837753</pub-id><pub-id pub-id-type="pmid">36639677</pub-id><pub-id pub-id-type="doi">10.1186/s12941-023-00553-7</pub-id></element-citation></ref><ref id="R82"><label>82</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lohrmann</surname><given-names>F</given-names></name><name><surname>Efstratiou</surname><given-names>A</given-names></name><name><surname>Sørensen</surname><given-names>UBS</given-names></name><name><surname>Creti</surname><given-names>R</given-names></name><name><surname>Decheva</surname><given-names>A</given-names></name><name><surname>Křížová</surname><given-names>P</given-names></name><etal/></person-group><article-title>Maternal Streptococcus agalactiae colonization in Europe: data from the multi-center DEVANI study</article-title><source>Infection</source><year>2024</year><month>Sep</month><day>8</day><date-in-citation>cited 2024 Nov 1</date-in-citation><comment>[Internet] Available from</comment><pub-id pub-id-type="pmid">39244714</pub-id></element-citation></ref><ref id="R83"><label>83</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shabayek</surname><given-names>S</given-names></name><name><surname>Ferrieri</surname><given-names>P</given-names></name><name><surname>Spellerberg</surname><given-names>B</given-names></name></person-group><article-title>Group B Streptococcal Colonization in African Countries: Prevalence, Capsular Serotypes, and Molecular Sequence Types</article-title><source>Pathogens</source><year>2021</year><month>Dec</month><day>10</day><volume>10</volume><issue>12</issue><elocation-id>1606</elocation-id><pub-id pub-id-type="pmcid">PMC8706430</pub-id><pub-id pub-id-type="pmid">34959562</pub-id><pub-id pub-id-type="doi">10.3390/pathogens10121606</pub-id></element-citation></ref><ref id="R84"><label>84</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jones</surname><given-names>S</given-names></name><name><surname>Newton</surname><given-names>P</given-names></name><name><surname>Payne</surname><given-names>M</given-names></name><name><surname>Furfaro</surname><given-names>L</given-names></name></person-group><article-title>Epidemiology, Antimicrobial Resistance, and Virulence Determinants of Group B Streptococcus in an Australian Setting</article-title><source>Front Microbiol</source><year>2022</year><month>Jun</month><day>14</day><volume>13</volume><elocation-id>839079</elocation-id><pub-id pub-id-type="pmcid">PMC9238357</pub-id><pub-id pub-id-type="pmid">35774462</pub-id><pub-id pub-id-type="doi">10.3389/fmicb.2022.839079</pub-id></element-citation></ref><ref id="R85"><label>85</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crestani</surname><given-names>C</given-names></name><name><surname>Forde</surname><given-names>TL</given-names></name><name><surname>Bell</surname><given-names>J</given-names></name><name><surname>Lycett</surname><given-names>SJ</given-names></name><name><surname>Oliveira</surname><given-names>LMA</given-names></name><name><surname>Pinto</surname><given-names>TCA</given-names></name><etal/></person-group><article-title>Genomic and functional determinants of host spectrum in Group B Streptococcus</article-title><person-group person-group-type="editor"><name><surname>Rajagopal</surname><given-names>L</given-names></name></person-group><source>PLoS Pathog</source><year>2024</year><month>Aug</month><day>12</day><volume>20</volume><issue>8</issue><elocation-id>e1012400</elocation-id><pub-id pub-id-type="pmcid">PMC11341095</pub-id><pub-id pub-id-type="pmid">39133742</pub-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1012400</pub-id></element-citation></ref><ref id="R86"><label>86</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oliveira</surname><given-names>LMA</given-names></name><name><surname>Simões</surname><given-names>LC</given-names></name><name><surname>Crestani</surname><given-names>C</given-names></name><name><surname>Costa</surname><given-names>NS</given-names></name><name><surname>Pantoja</surname><given-names>JCF</given-names></name><name><surname>Rabello</surname><given-names>RF</given-names></name><etal/></person-group><article-title>Group B <italic>Streptococcus</italic> Sequence Type 103 as Human and Bovine Pathogen, Brazil</article-title><source>Emerg Infect Dis</source><year>2024</year><month>Aug</month><volume>30</volume><issue>8</issue><date-in-citation>cited 2024 Aug 2</date-in-citation><comment>[Internet] Available from: <ext-link ext-link-type="uri" xlink:href="https://wwwnc.cdc.gov/eid/article/30/8/23-1575_article">https://wwwnc.cdc.gov/eid/article/30/8/23-1575_article</ext-link></comment><pub-id pub-id-type="pmcid">PMC11286041</pub-id><pub-id pub-id-type="pmid">39043455</pub-id><pub-id pub-id-type="doi">10.3201/eid3008.231575</pub-id></element-citation></ref><ref id="R87"><label>87</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oliveira</surname><given-names>LMAD</given-names></name><name><surname>Simões</surname><given-names>LC</given-names></name><name><surname>Crestani</surname><given-names>C</given-names></name><name><surname>Costa</surname><given-names>NS</given-names></name><name><surname>Pantoja</surname><given-names>JCDF</given-names></name><name><surname>Rabello</surname><given-names>RF</given-names></name><etal/></person-group><article-title>Long-Term Co-Circulation of Host-Specialist and Host-Generalist Lineages of Group B Streptococcus in Brazilian Dairy Cattle with Heterogeneous Antimicrobial Resistance Profiles</article-title><source>Antibiotics</source><year>2024</year><month>Apr</month><day>25</day><volume>13</volume><issue>5</issue><fpage>389</fpage><pub-id pub-id-type="pmcid">PMC11117364</pub-id><pub-id pub-id-type="pmid">38786118</pub-id><pub-id pub-id-type="doi">10.3390/antibiotics13050389</pub-id></element-citation></ref><ref id="R88"><label>88</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lambertsen</surname><given-names>L</given-names></name><name><surname>Ekelund</surname><given-names>K</given-names></name><name><surname>Skovsted</surname><given-names>IC</given-names></name><name><surname>Liboriussen</surname><given-names>A</given-names></name><name><surname>Slotved</surname><given-names>HC</given-names></name></person-group><article-title>Characterisation of invasive group B streptococci from adults in Denmark 1999 to 2004</article-title><source>Eur J Clin Microbiol Infect Dis</source><year>2010</year><month>Sep</month><volume>29</volume><issue>9</issue><fpage>1071</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">20676713</pub-id></element-citation></ref><ref id="R89"><label>89</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lambertsen</surname><given-names>LM</given-names></name><name><surname>Ingels</surname><given-names>H</given-names></name><name><surname>Schønheyder</surname><given-names>HC</given-names></name><name><surname>Hoffmann</surname><given-names>S</given-names></name></person-group><article-title>Nationwide laboratory-based surveillance of invasive beta-haemolytic streptococci in Denmark from 2005 to 2011</article-title><source>Clinical Microbiology and Infection</source><year>2014</year><month>Apr</month><volume>20</volume><issue>4</issue><fpage>O216</fpage><lpage>23</lpage><pub-id pub-id-type="pmcid">PMC4232002</pub-id><pub-id pub-id-type="pmid">24125634</pub-id><pub-id pub-id-type="doi">10.1111/1469-0691.12378</pub-id></element-citation></ref><ref id="R90"><label>90</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosini</surname><given-names>R</given-names></name><name><surname>Campisi</surname><given-names>E</given-names></name><name><surname>De Chiara</surname><given-names>M</given-names></name><name><surname>Tettelin</surname><given-names>H</given-names></name><name><surname>Rinaudo</surname><given-names>D</given-names></name><name><surname>Toniolo</surname><given-names>C</given-names></name><etal/></person-group><article-title>Genomic Analysis Reveals the Molecular Basis for Capsule Loss in the Group B Streptococcus Population</article-title><person-group person-group-type="editor"><name><surname>Miyaji</surname><given-names>EN</given-names></name></person-group><source>PLoS ONE</source><year>2015</year><month>May</month><day>6</day><volume>10</volume><issue>5</issue><elocation-id>e0125985</elocation-id><pub-id pub-id-type="pmcid">PMC4422693</pub-id><pub-id pub-id-type="pmid">25946017</pub-id><pub-id pub-id-type="doi">10.1371/journal.pone.0125985</pub-id></element-citation></ref><ref id="R91"><label>91</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Björnsdóttir</surname><given-names>ES</given-names></name><name><surname>Martins</surname><given-names>ER</given-names></name><name><surname>Erlendsdóttir</surname><given-names>H</given-names></name><name><surname>Haraldsson</surname><given-names>G</given-names></name><name><surname>Melo-Cristino</surname><given-names>J</given-names></name><name><surname>Kristinsson</surname><given-names>KG</given-names></name><etal/></person-group><article-title>Changing epidemiology of group B streptococcal infections among adults in Iceland: 1975–2014</article-title><source>Clinical Microbiology and Infection</source><year>2016</year><month>Apr</month><volume>22</volume><issue>4</issue><elocation-id>379.e9-379.e16</elocation-id><pub-id pub-id-type="pmid">26691681</pub-id></element-citation></ref><ref id="R92"><label>92</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Slotved</surname><given-names>HC</given-names></name><name><surname>Hoffmann</surname><given-names>S</given-names></name></person-group><article-title>Evaluation of procedures for typing of group B <italic>Streptococcus</italic> : a retrospective study</article-title><source>PeerJ</source><year>2017</year><month>Mar</month><day>16</day><volume>5</volume><elocation-id>e3105</elocation-id><pub-id pub-id-type="pmcid">PMC5357338</pub-id><pub-id pub-id-type="pmid">28321367</pub-id><pub-id pub-id-type="doi">10.7717/peerj.3105</pub-id></element-citation></ref><ref id="R93"><label>93</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Slotved</surname><given-names>HC</given-names></name><name><surname>Hoffmann</surname><given-names>S</given-names></name></person-group><article-title>The Epidemiology of Invasive Group B Streptococcus in Denmark From 2005 to 2018</article-title><source>Front Public Health</source><year>2020</year><month>Mar</month><day>10</day><volume>8</volume><fpage>40</fpage><pub-id pub-id-type="pmcid">PMC7076979</pub-id><pub-id pub-id-type="pmid">32211361</pub-id><pub-id pub-id-type="doi">10.3389/fpubh.2020.00040</pub-id></element-citation></ref><ref id="R94"><label>94</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Creti</surname><given-names>R</given-names></name><name><surname>Imperi</surname><given-names>M</given-names></name><name><surname>Pataracchia</surname><given-names>M</given-names></name><name><surname>Alfarone</surname><given-names>G</given-names></name><name><surname>Recchia</surname><given-names>S</given-names></name><name><surname>Baldassarri</surname><given-names>L</given-names></name></person-group><article-title>Identification and molecular characterization of a S. agalactiae strain lacking the capsular locus</article-title><source>Eur J Clin Microbiol Infect Dis</source><year>2012</year><month>Mar</month><volume>31</volume><issue>3</issue><fpage>233</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">21614482</pub-id></element-citation></ref><ref id="R95"><label>95</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Slotved</surname><given-names>HC</given-names></name><name><surname>Fuursted</surname><given-names>K</given-names></name><name><surname>Kavalari</surname><given-names>ID</given-names></name><name><surname>Hoffmann</surname><given-names>S</given-names></name></person-group><article-title>Molecular Identification of Invasive Non-typeable Group B Streptococcus Isolates From Denmark (2015 to 2017)</article-title><source>Front Cell Infect Microbiol</source><year>2021</year><month>Mar</month><day>29</day><volume>11</volume><elocation-id>571901</elocation-id><pub-id pub-id-type="pmcid">PMC8039440</pub-id><pub-id pub-id-type="pmid">33854981</pub-id><pub-id pub-id-type="doi">10.3389/fcimb.2021.571901</pub-id></element-citation></ref><ref id="R96"><label>96</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perme</surname><given-names>T</given-names></name><name><surname>Golparian</surname><given-names>D</given-names></name><name><surname>Bombek Ihan</surname><given-names>M</given-names></name><name><surname>Rojnik</surname><given-names>A</given-names></name><name><surname>Lucovnik</surname><given-names>M</given-names></name><name><surname>Kornhauser Cerar</surname><given-names>L</given-names></name><etal/></person-group><article-title>Genomic and phenotypic characterisation of invasive neonatal and colonising group B Streptococcus isolates from Slovenia, 2001-2018</article-title><source>BMC Infect Dis</source><year>2020</year><month>Dec</month><volume>20</volume><issue>1</issue><fpage>958</fpage><pub-id pub-id-type="pmcid">PMC7739447</pub-id><pub-id pub-id-type="pmid">33327946</pub-id><pub-id pub-id-type="doi">10.1186/s12879-020-05599-y</pub-id></element-citation></ref><ref id="R97"><label>97</label><element-citation publication-type="confproc"><person-group person-group-type="author"><name><surname>Slotved</surname><given-names>HC</given-names></name></person-group><source>Decoding Streptococcus agalactiae: Phenotyping vs. Genotyping for Diagnostic Purposes</source><conf-name>Plenary presented at: 3rd International Symposium on ‘Streptococcus agalactiae’ Disease (ISSAD)</conf-name><conf-loc>Rio de Janeiro, Brazil</conf-loc><year>2023</year><month>Oct</month><day>16</day><comment>[oral presentation]. 3rd International Symposium on ‘Streptococcus agalactiae’ Disease (ISSAD); 2023 Oct 16; Rio de Janeiro, Brazil</comment></element-citation></ref><ref id="R98"><label>98</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Madhi</surname><given-names>SA</given-names></name><name><surname>Anderson</surname><given-names>AS</given-names></name><name><surname>Absalon</surname><given-names>J</given-names></name><name><surname>Radley</surname><given-names>D</given-names></name><name><surname>Simon</surname><given-names>R</given-names></name><name><surname>Jongihlati</surname><given-names>B</given-names></name><etal/></person-group><article-title>Potential for Maternally Administered Vaccine for Infant Group B Streptococcus</article-title><source>N Engl J Med</source><year>2023</year><month>Jul</month><day>20</day><volume>389</volume><issue>3</issue><fpage>215</fpage><lpage>27</lpage><pub-id pub-id-type="pmid">37467497</pub-id></element-citation></ref><ref id="R99"><label>99</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brokaw</surname><given-names>A</given-names></name><name><surname>Nguyen</surname><given-names>S</given-names></name><name><surname>Quach</surname><given-names>P</given-names></name><name><surname>Orvis</surname><given-names>A</given-names></name><name><surname>Furuta</surname><given-names>A</given-names></name><name><surname>Johansson-Lindbom</surname><given-names>B</given-names></name><etal/></person-group><article-title>A Recombinant Alpha-Like Protein Subunit Vaccine (GBS-NN) Provides Protection in Murine Models of Group B <italic>Streptococcus</italic> Infection</article-title><source>The Journal of Infectious Diseases</source><year>2022</year><month>Aug</month><day>12</day><volume>226</volume><issue>1</issue><fpage>177</fpage><lpage>87</lpage><pub-id pub-id-type="pmcid">PMC9890916</pub-id><pub-id pub-id-type="pmid">35429401</pub-id><pub-id pub-id-type="doi">10.1093/infdis/jiac148</pub-id></element-citation></ref><ref id="R100"><label>100</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crestani</surname><given-names>C</given-names></name><name><surname>Seligsohn</surname><given-names>D</given-names></name><name><surname>Forde</surname><given-names>TL</given-names></name><name><surname>Zadoks</surname><given-names>RN</given-names></name></person-group><article-title>How GBS Got Its Hump: Genomic Analysis of Group B Streptococcus from Camels Identifies Host Restriction as well as Mobile Genetic Elements Shared across Hosts and Pathogens</article-title><source>Pathogens</source><year>2022</year><month>Sep</month><day>8</day><volume>11</volume><issue>9</issue><elocation-id>1025</elocation-id><pub-id pub-id-type="pmcid">PMC9504112</pub-id><pub-id pub-id-type="pmid">36145457</pub-id><pub-id pub-id-type="doi">10.3390/pathogens11091025</pub-id></element-citation></ref><ref id="R101"><label>101</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sirimanapong</surname><given-names>W</given-names></name><name><surname>Phước</surname><given-names>NN</given-names></name><name><surname>Crestani</surname><given-names>C</given-names></name><name><surname>Chen</surname><given-names>S</given-names></name><name><surname>Zadoks</surname><given-names>RN</given-names></name></person-group><article-title>Geographical, Temporal and Host-Species Distribution of Potentially Human-Pathogenic Group B Streptococcus in Aquaculture Species in Southeast Asia</article-title><source>Pathogens</source><year>2023</year><month>Mar</month><day>28</day><volume>12</volume><issue>4</issue><fpage>525</fpage><pub-id pub-id-type="pmcid">PMC10146238</pub-id><pub-id pub-id-type="pmid">37111411</pub-id><pub-id pub-id-type="doi">10.3390/pathogens12040525</pub-id></element-citation></ref><ref id="R102"><label>102</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Domelier</surname><given-names>AS</given-names></name><name><surname>van der Mee-Marquet</surname><given-names>N</given-names></name><name><surname>Sizaret</surname><given-names>PY</given-names></name><name><surname>Héry-Arnaud</surname><given-names>G</given-names></name><name><surname>Lartigue</surname><given-names>MF</given-names></name><name><surname>Mereghetti</surname><given-names>L</given-names></name><etal/></person-group><article-title>Molecular Characterization and Lytic Activities of Streptococcus agalactiae Bacteriophages and Determination of Lysogenic-Strain Features</article-title><source>JB</source><year>2009</year><month>Aug</month><day>1</day><volume>191</volume><issue>15</issue><fpage>4776</fpage><lpage>85</lpage><pub-id pub-id-type="pmcid">PMC2715722</pub-id><pub-id pub-id-type="pmid">19465660</pub-id><pub-id pub-id-type="doi">10.1128/JB.00426-09</pub-id></element-citation></ref><ref id="R103"><label>103</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Ellson</surname><given-names>CD</given-names></name><name><surname>Yaffe</surname><given-names>MB</given-names></name></person-group><chapter-title>PX Domains</chapter-title><source>Handbook of Cell Signaling [Internet]</source><publisher-name>Elsevier</publisher-name><year>2010</year><fpage>1103</fpage><lpage>9</lpage><date-in-citation>cited 2024 Sep 13</date-in-citation><comment>Available from: <ext-link ext-link-type="uri" xlink:href="https://linkinghub.elsevier.com/retrieve/pii/B9780123741455001376">https://linkinghub.elsevier.com/retrieve/pii/B9780123741455001376</ext-link></comment></element-citation></ref><ref id="R104"><label>104</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Chandra</surname><given-names>M</given-names></name><name><surname>Collins</surname><given-names>BM</given-names></name></person-group><chapter-title>The Phox Homology (PX) Domain</chapter-title><person-group person-group-type="editor"><name><surname>Atassi</surname><given-names>MZ</given-names></name></person-group><source>Protein Reviews – Purinergic Receptors</source><series>Advances in Experimental Medicine and Biology</series><publisher-name>Springer International Publishing</publisher-name><publisher-loc>Cham</publisher-loc><year>2018</year><volume>1111</volume><fpage>1</fpage><lpage>17</lpage><date-in-citation>cited 2024 Sep 6</date-in-citation><comment>[Internet]</comment><pub-id pub-id-type="doi">10.1007/5584_2018_185</pub-id></element-citation></ref><ref id="R105"><label>105</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berbel</surname><given-names>D</given-names></name><name><surname>Càmara</surname><given-names>J</given-names></name><name><surname>González-Díaz</surname><given-names>A</given-names></name><name><surname>Cubero</surname><given-names>M</given-names></name><name><surname>López De Egea</surname><given-names>G</given-names></name><name><surname>Martí</surname><given-names>S</given-names></name><etal/></person-group><article-title>Deciphering mobile genetic elements disseminating macrolide resistance in <italic>Streptococcus pyogenes</italic> over a 21 year period in Barcelona, Spain</article-title><source>Journal of Antimicrobial Chemotherapy</source><year>2021</year><month>Jul</month><day>15</day><volume>76</volume><issue>8</issue><fpage>1991</fpage><lpage>2003</lpage><pub-id pub-id-type="pmid">34015100</pub-id></element-citation></ref><ref id="R106"><label>106</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Zhao</surname><given-names>C</given-names></name><name><surname>He</surname><given-names>W</given-names></name><name><surname>Zhang</surname><given-names>F</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Cao</surname><given-names>B</given-names></name><etal/></person-group><article-title>High Prevalence of Fluoroquinolone-Resistant Group B Streptococci among Clinical Isolates in China and Predominance of Sequence Type 19 with Serotype III</article-title><source>Antimicrob Agents Chemother</source><year>2013</year><month>Mar</month><volume>57</volume><issue>3</issue><fpage>1538</fpage><lpage>41</lpage><pub-id pub-id-type="pmcid">PMC3591929</pub-id><pub-id pub-id-type="pmid">23295933</pub-id><pub-id pub-id-type="doi">10.1128/AAC.02317-12</pub-id></element-citation></ref><ref id="R107"><label>107</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>CJ</given-names></name><name><surname>Lai</surname><given-names>JF</given-names></name><name><surname>Huang</surname><given-names>IW</given-names></name><name><surname>Hsieh</surname><given-names>LY</given-names></name><name><surname>Wang</surname><given-names>HY</given-names></name><name><surname>Shiau</surname><given-names>YR</given-names></name><etal/></person-group><article-title>Multiclonal emergence of levofloxacin-resistant group B Streptococcus, Taiwan</article-title><source>Journal of Antimicrobial Chemotherapy</source><year>2017</year><month>Dec</month><day>1</day><volume>72</volume><issue>12</issue><fpage>3263</fpage><lpage>71</lpage><pub-id pub-id-type="pmid">28961888</pub-id></element-citation></ref><ref id="R108"><label>108</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>K</given-names></name><name><surname>Zhu</surname><given-names>D</given-names></name><name><surname>Tao</surname><given-names>Y</given-names></name><name><surname>Xie</surname><given-names>L</given-names></name><name><surname>Han</surname><given-names>L</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><etal/></person-group><article-title>New genetic context of lnu(B) composed of two multi-resistance gene clusters in clinical Streptococcus agalactiae ST-19 strains</article-title><source>Antimicrob Resist Infect Control</source><year>2019</year><month>Dec</month><volume>8</volume><issue>1</issue><fpage>117</fpage><pub-id pub-id-type="pmcid">PMC6632187</pub-id><pub-id pub-id-type="pmid">31346458</pub-id><pub-id pub-id-type="doi">10.1186/s13756-019-0563-x</pub-id></element-citation></ref><ref id="R109"><label>109</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname><given-names>K</given-names></name><name><surname>Gao</surname><given-names>C</given-names></name><name><surname>Huang</surname><given-names>L</given-names></name><name><surname>Guan</surname><given-names>X</given-names></name><name><surname>Ji</surname><given-names>W</given-names></name><name><surname>Chang</surname><given-names>CY</given-names></name><etal/></person-group><article-title>Predominance of III/ST19 and Ib/ST10 Lineages With High Multidrug Resistance in Fluoroquinolone-Resistant Group B Streptococci Isolates in Which a New Integrative and Conjugative Element Was Identified</article-title><source>Front Microbiol</source><year>2021</year><month>Jan</month><day>25</day><volume>11</volume><elocation-id>609526</elocation-id><pub-id pub-id-type="pmcid">PMC7868321</pub-id><pub-id pub-id-type="pmid">33569045</pub-id><pub-id pub-id-type="doi">10.3389/fmicb.2020.609526</pub-id></element-citation></ref><ref id="R110"><label>110</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhi</surname><given-names>Y</given-names></name><name><surname>Ji</surname><given-names>HJ</given-names></name><name><surname>Jung</surname><given-names>JH</given-names></name><name><surname>Byun</surname><given-names>EB</given-names></name><name><surname>Kim</surname><given-names>WS</given-names></name><name><surname>Lin</surname><given-names>SM</given-names></name><etal/></person-group><article-title>Molecular Characteristics of IS <italic>1216</italic> Carrying Multidrug Resistance Gene Cluster in Serotype III/Sequence Type 19 Group B Streptococcus</article-title><person-group person-group-type="editor"><name><surname>Torres</surname><given-names>AG</given-names></name></person-group><source>mSphere</source><year>2021</year><month>Aug</month><day>25</day><volume>6</volume><issue>4</issue><elocation-id>e00543-21</elocation-id><pub-id pub-id-type="pmcid">PMC8386385</pub-id><pub-id pub-id-type="pmid">34319128</pub-id><pub-id pub-id-type="doi">10.1128/mSphere.00543-21</pub-id></element-citation></ref><ref id="R111"><label>111</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Gao</surname><given-names>W</given-names></name><name><surname>Jia</surname><given-names>Z</given-names></name><name><surname>Yao</surname><given-names>K</given-names></name><name><surname>Yang</surname><given-names>J</given-names></name><name><surname>Tong</surname><given-names>J</given-names></name><etal/></person-group><article-title>Characterization of Group B Streptococcus Recovered from Pregnant Women and Newborns Attending in a Hospital in Beijing, China</article-title><source>IDR</source><year>2023</year><month>Apr</month><volume>16</volume><fpage>2549</fpage><lpage>59</lpage><pub-id pub-id-type="pmcid">PMC10150791</pub-id><pub-id pub-id-type="pmid">37138839</pub-id><pub-id pub-id-type="doi">10.2147/IDR.S395942</pub-id></element-citation></ref><ref id="R112"><label>112</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pechere</surname><given-names>JC</given-names></name><name><surname>Dugal</surname><given-names>R</given-names></name></person-group><article-title>Clinical Pharmacokinetics of Aminoglycoside Antibiotics: Clinical Pharmacokinetics</article-title><year>1979</year><volume>4</volume><issue>3</issue><fpage>170</fpage><lpage>99</lpage><pub-id pub-id-type="pmid">383354</pub-id></element-citation></ref><ref id="R113"><label>113</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>MK</given-names></name><name><surname>Nightingale</surname><given-names>CH</given-names></name></person-group><chapter-title>Pharmcokinetics and Pharmacodynamics of the Fluoroquinolones</chapter-title><source>The Quinolones</source><publisher-name>Elsevier;</publisher-name><year>2000</year><fpage>169</fpage><lpage>202</lpage><date-in-citation>cited 2024 Sep 5</date-in-citation><comment>[Internet] Available from: <ext-link ext-link-type="uri" xlink:href="https://linkinghub.elsevier.com/retrieve/pii/B9780120595174500064">https://linkinghub.elsevier.com/retrieve/pii/B9780120595174500064</ext-link></comment></element-citation></ref><ref id="R114"><label>114</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Watkins</surname><given-names>RR</given-names></name><name><surname>Bonomo</surname><given-names>RA</given-names></name></person-group><chapter-title>β-Lactam Antibiotics</chapter-title><source>Infectious Diseases</source><publisher-name>Elsevier</publisher-name><year>2017</year><fpage>1203</fpage><lpage>1216</lpage><elocation-id>e2</elocation-id><date-in-citation>cited 2024 Sep 5</date-in-citation><comment>[Internet] Available from: <ext-link ext-link-type="uri" xlink:href="https://linkinghub.elsevier.com/retrieve/pii/B9780702062858001404">https://linkinghub.elsevier.com/retrieve/pii/B9780702062858001404</ext-link></comment></element-citation></ref></ref-list></back><floats-group><boxed-text id="BX1" position="float" orientation="portrait"><caption><title>Data summary</title></caption><p>Supplementary results and figures can be found in Supplementary Material 1. Supplementary tables can be found in Supplementary Material 2. All datasets analysed in this study are detailed in the Supplementary Materials. Metadata about the genomes analysed can be found in the microreact project created for this study: <ext-link ext-link-type="uri" xlink:href="https://microreact.org/project/gbs-pangenomic-analysis">https://microreact.org/project/gbs-pangenomic-analysis</ext-link>.</p></boxed-text><boxed-text id="BX2" position="float" orientation="portrait"><caption><title>Impact statement</title></caption><p>In Latin America studies on the epidemiology of Group B Streptococcus (GBS) are scarce, especially those describing clonal complex and serotype distribution, and the role of prophages in GBS epidemiology has not been studied. This article addresses the first genomic characterisation of the human-isolated GBS population in Latin America based on whole genome sequencing data, with special focus on the analysis of prophage content. We determine the clonal complex and serotype distribution of 365 GBS isolates collected from clinical samples in an Argentinian multicenter study and analyse the presence of prophages and virulence and antibiotic resistance determinants in the context of the epidemiological data. Through these analyses, we were able to determine how GBS population structure in Argentina differs from other parts of the world and to predict the potential coverage of the in-development GBS vaccines. We also found a possible association between the carriage of certain types of prophages and an increased GBS pathogenicity. In the context of increased global efforts to develop new strategies to prevent GBS infections through vaccine development, this study makes a significant contribution to our understanding of the global GBS population structure.</p></boxed-text><fig id="F1" position="float"><label>Figure 1</label><caption><title>Maximum likelihood phylogenetic tree of the 468 GBS genomes analysed here.</title><p>The tree was midpoint rooted, with nodes coloured according to clonal complex (CC). The inner ring represents the capsular type and the outer ring the country of isolation. Support values (SH-aLRT/ultrafast Bootstrap) are shown as labels at the root of the main clades. The dataset is available at: <ext-link ext-link-type="uri" xlink:href="https://microreact.org/project/gbs-pangenomic-analysis">https://microreact.org/project/gbs-pangenomic-analysis</ext-link></p></caption><graphic xlink:href="EMS202321-f001"/></fig><fig id="F2" position="float"><label>Figure 2</label><caption><title>Lineage distribution among Argentinian GBS isolates according to collection.</title><p>iiGBS: GBS recovered from infant invasive infections; niGBS: GBS recovered from non-infant invasive infections; uGBS: GBS recovered from urinary infections; cGBS: GBS recovered from pregnant women during prenatal screenings. The lineages that differ significantly (<italic>p</italic>&lt;0.05) between collections are marked with *.</p></caption><graphic xlink:href="EMS202321-f002"/></fig><fig id="F3" position="float"><label>Figure 3</label><caption><title>Phylogenetic tree of GBS isolates annotated with the distribution of prophages, virulence determinants and antibiotic resistance determinants.</title><p>Core-SNP maximum likelihood phylogenetic tree, midpoint rooted, with nodes coloured by clonal complex. Strains metadata are shown as coloured blocks. IRE: Immune response evasion; TD: tissue damage; ATI: adherence to host tissues and invasion; MLS: macrolides/lincosamides/streptogramins; QL: quinolones; NT: non-typeable. The virulence genes of the <italic>cyl</italic> operon, besides <italic>cyl</italic>A and <italic>acp</italic>C, were present in all the genomes and are not included in the figure. <ext-link ext-link-type="uri" xlink:href="https://microreact.org/project/gbs-pangenomic-analysis">https://microreact.org/project/gbs-pangenomic-analysis</ext-link></p></caption><graphic xlink:href="EMS202321-f003"/></fig><fig id="F4" position="float"><label>Figure 4</label><caption><title>Distribution of prophages in Argentinian GBS isolates according to collection.</title><p>iiGBS: GBS recovered from infant invasive infections; niGBS: GBS recovered from non-infant invasive infections; uGBS: GBS recovered from urinary infections; cGBS: GBS recovered from pregnant women during prenatal screenings. Significant difference (<italic>p</italic>&lt;0.05) in distribution of a prophage type is shown with an *, and of an integrase type with an #.</p></caption><graphic xlink:href="EMS202321-f004"/></fig><fig id="F5" position="float"><label>Figure 5</label><caption><title>Distribution of GBS lineages according to multi-drug resistance determinants profile.</title><p>AG: aminoglycosides; CHL: chloramphenicol; MLS: macrolides/lincosamides/streptogramins; TET: tetracyclines; STR: streptothricin; QL: quinolones; BL: beta-lactams; VAN: vancomycin; TRI: trimethoprim.</p></caption><graphic xlink:href="EMS202321-f005"/></fig><table-wrap id="T1" position="float" orientation="portrait"><label>Table 1</label><caption><title>Novel variants of PBP2x found in analysed GBS genomes</title></caption><table frame="hsides" rules="groups"><thead><tr style="background-color:#0070c0"><th align="center" valign="middle"><styled-content style="color:#FFFFFF">Strain</styled-content></th><th align="center" valign="middle"><styled-content style="color:#FFFFFF">PBP2x Mutation</styled-content></th><th align="center" valign="middle"><styled-content style="color:#FFFFFF">n GBS</styled-content></th><th align="center" valign="middle"><styled-content style="color:#FFFFFF">Country</styled-content></th><th align="center" valign="middle"><styled-content style="color:#FFFFFF">Strain origin</styled-content></th><th align="center" valign="middle"><styled-content style="color:#FFFFFF">Lineage</styled-content></th><th align="center" valign="middle"><styled-content style="color:#FFFFFF">MIC PEN<xref ref-type="table-fn" rid="TFN1">*</xref> (mg/ml)</styled-content></th><th align="center" valign="middle"><styled-content style="color:#FFFFFF">MIC PEN Interpretation</styled-content></th></tr></thead><tbody><tr style="background-color:#eaeaea"><td align="left" valign="middle">JN_AR_GBS346</td><td align="center" valign="middle">G554S</td><td align="center" valign="middle">1</td><td align="center" valign="middle">Argentina</td><td align="center" valign="middle">uGBS</td><td align="center" valign="middle">CC12/Ib</td><td align="center" valign="middle">0.03</td><td align="center" valign="middle">Susceptible</td></tr><tr><td align="left" valign="middle">JN_AR_GBS285</td><td align="center" valign="middle">I377V, A559V, G627V</td><td align="center" valign="middle">1</td><td align="center" valign="middle">Argentina</td><td align="center" valign="middle">uGBS</td><td align="center" valign="middle">CC17/III</td><td align="center" valign="middle">0.03</td><td align="center" valign="middle">Susceptible</td></tr><tr style="background-color:#eaeaea"><td align="left" valign="middle">JN_AR_GBS450</td><td align="center" valign="middle">I377V, V510I, A559V</td><td align="center" valign="middle">1</td><td align="center" valign="middle">Argentina</td><td align="center" valign="middle">uGBS</td><td align="center" valign="middle">CC23/Ia</td><td align="center" valign="middle">0.03</td><td align="center" valign="middle">Susceptible</td></tr><tr><td align="left" valign="middle">JN_AR_GBS41<break/>JN_AR_GBS164<break/>JN_AR_GBS270</td><td align="center" valign="middle">P529S</td><td align="center" valign="middle">3</td><td align="center" valign="middle">Argentina</td><td align="center" valign="middle">niGBS<break/>cGBS<break/>uGBS</td><td align="center" valign="middle">CC1/V</td><td align="center" valign="middle">0.03</td><td align="center" valign="middle">Susceptible</td></tr><tr style="background-color:#eaeaea"><td align="left" valign="middle">JN_AR_GBS287<break/>JN_AR_GBS288</td><td align="center" valign="middle">T345l, I377V, V510I</td><td align="center" valign="middle">2</td><td align="center" valign="middle">Argentina</td><td align="center" valign="middle">uGBS</td><td align="center" valign="middle">CC452/la</td><td align="center" valign="middle">0.03</td><td align="center" valign="middle">Susceptible</td></tr><tr><td align="left" valign="middle">C∪GBS59l</td><td align="center" valign="middle">I607X</td><td align="center" valign="middle">1</td><td align="center" valign="middle">China</td><td align="center" valign="middle">niGBS</td><td align="center" valign="middle">CC12/lb</td><td align="center" valign="middle">No data</td><td align="center" valign="middle">No data</td></tr></tbody></table><table-wrap-foot><fn id="TFN1"><p id="P65">MIC: Minimum inhibitory concentration; PEN: Penicillin; uGBS: GBS isolated from urinary infections; niGBS: GBS isolated from non-infant invasive infections; cGBS: GBS isolated from vaginal colonisation. *(<xref ref-type="bibr" rid="R4">4</xref>,<xref ref-type="bibr" rid="R5">5</xref>).</p></fn></table-wrap-foot></table-wrap></floats-group></article>